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ABSTRACT
INVESTIGATIONS ON THE USE OF ION MOBILITY 
SPECTROMETRY FOR CLINICAL CHEMISTRY APPLICATIONS
Henri Parson Patten 
Old Dominion University, 2000 
Director: Dr. Edward J. Poziomek
The major objective o f this research is to examine ion mobility spectrometry as 
a rapid screening tool for specific application to clinical chemistry research and 
laboratory use. Methodology was developed for target analytes representing several 
classes of physiologically active substances, including anesthetics, illicit drugs, and 
their metabolites. The IMS characteristics o f animal tissues and other compounds such 
as amino acids and proteins were determined. Quality assurance and control 
procedures were developed for specific quality data objectives. Criteria were 
established relating to use of IMS for assessing the precision and accuracy of data, 
qualitative screening, and semi-quantitative analyses.
It was found that animal tissues and plasma harvested from rabbits can be 
characterized using IMS. The mobility spectra o f these tissues were also found to 
contain peaks assigned to the anesthetics, Rompun and Ketaset, heparin, and ecgonine 
methyl ester (EME), a cocaine metabolite. Enhancement and retardation effects were 
identified with cocaine and its metabolites as well as with heroin, and its metabolite 
6-acetylmorphine. A nonspecific interaction of heroin and morphine with animal 
tissues and different proteins was also identified using IMS. It was concluded that the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
use of IMS for clinical applications is feasible. The benefits and limitations of using 
IMS for clinical chemistry applications were identified.
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Ion Mobility Spectrometry for Clinical Chemistry Applications
Ion mobility spectrometry (IMS) has historically been used to analyze 
environmental hazards, chemical warfare agents, explosives, and drugs on surfaces and 
in ambient air. This fast and sensitive technique has not, however, been extended for 
use in clinical laboratories. Clinical chemistry, which incorporates many aspects of 
physiology and diagnostic medicine, is a dynamic science which continually needs new 
measurement technologies. IMS is a simple technique that offers promise for clinical 
chemistry applications in view o f its diversity as an analytical tool. IMS offers the 
potential of detecting target analytes in the timely, efficient, and cost effective manner 
required in a clinical chemistry setting.
Ion Mobility Spectrometry (IMS)
IMS is an analytical technique that characterizes chemical substances through 
gas-phase ion mobilities. These substances, initially in gas, liquid, or solid form, are 
vaporized and allowed to flow into the reaction region of a drift tube at atmospheric 
pressure. Most IMS instruments use ambient air pumped into the spectrometer through 
a semipermeable membrane. Molecules are ionized and the product ions are allowed to 
enter into the drift region under a weak electric current for mobility analysis. Ionization 
preferences of analytes, and mobility differences of the ions or ion clusters give
The model for this dissertation was Analytica Chimica Acta
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specificity. Analysis and characterization are based on analyte separations due to ionic 
mobilities rather than masses; this distinguishes IMS from mass spectrometry (MS). 
During analysis, the product ions are measured when they collide with a detector; 
current is recorded continuously versus time, and produces a spectrum [1 ]. An example 
using cocaine is given in Fig. 1.
Although the required chemistry and physics o f ions in ambient air were 
developed in the early 1900’s, it was 1970 when IMS was first introduced (Cohen and 
Karasek [2.3]) as a technique for organic chemical analysis. Initially thought o f as a 
type of chromatography, many researchers looked for IMS to become an alternative for 
mass spectrometry. Due to the lack o f information concerning ion molecule chemistry, 
ion behavior at atmospheric pressure, and applicability to mixtures, many publications 
of the 1980s rejected IMS, deeming the instrument to be confusing and too complicated 
for practical application. Nevertheless, research continued, and IMS was successfully 
developed by military agencies as a sensitive detector for chemical warfare agents [4], 
Most exploratory research done during this period was conducted by a small number o f 
universities and government laboratories. During the 1990’s a renewed interest in IMS 
technology emerged due to refinements in instrumentation and an increased 
understanding o f its fundamental principles. When compared to conventional analytical 
techniques. IMS provides an abundance of information, without the power, size, and 
weight demands of other techniques such as gas chromatography-mass spectrometry 
(GC/MS) and Fourier-transform infrared (FT/IR) spectroscopy. Today, IMS is being 
employed to detect and analyze environmental analytes, [5-7] illicit drugs, [8-11] and































8 10 12 14 16 18 20
Drift Time (ms)
Fig. 1. IMS mobility spectrum of 75 ng cocaine hydrochloride. The characteristic peak 
of cocaine has a K<, value o f 1.16 c n rV 's '1. The peak at Ko, 1-51 c n ^ V 'V  is a thermal 
decomposition product o f cocaine formed in the spectrometer.
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explosives [12-17], It continues as an important field method for chemical warfare 
agents. Table 1 gives a few examples o f the types of chemicals that have been detected 
with IMS.
IMS technology continues to be reviewed for new applications in analytical 
chemistry [4, 18-22]. Attributes of small size, low weight, and low power have led IMS 
to be considered for on-site analytical applications. Ionization chemistry can be 
modified to focus IMS selectivity and to allow an analyzer to be developed for specific 
scenarios [1 ]. Research on ionization methodology, behavior of ions in air at 
atmospheric pressure, and data processing continues. Improvements in instrument 
design, and the coupling o f IMS technology with other analytical instruments, such as 
gas chromatography (GC-IMS) and mass spectrometry (IMS-MS), hold much promise 
for increased utility and new applications.
Instrumentation. Available IMS instrumentation ranges from sophisticated 
laboratory models to hand-held field units. IMS electronics include a high voltage 
supply, shutter control, a signal processor, and a data system. The basic utilities or
Table 1
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mechanics include inlet control, temperature control, and flow control [23]. A typical 
IMS system can be divided into several sections: sample introduction, reaction region, 
ion drift region, and ion collection/detection. A schematic of the Barringer IONSCAN 
IMS system is shown in Fig. 2 [24],
Analyte vapors are introduced either by direct sampling of vapors or by thermal 
desorption from a solid matrix such as a swipe material. In the Barringer IONSCAN. 
the solid and liquid samples are introduced through a desorber inlet. The sample is 
deposited on a membrane (e.g., Teflon, fiberglass, or paper). The membrane is placed 
into the IONSCAN where the analyte is desorbed as vapors. These vapors pass into the 
reaction chamber in a flow of carrier gas, where they are ionized using 63Ni. Product 
ions are gated into the drift tube where the drift times in an electric field are measured. 
Operations are normally performed at atmospheric pressure using ambient air as the 
carrier and drift gases, though other gases can also be used.
Drift tubes are constructed with different designs, dimensions, operating 
parameters and materials. Most drift tubes are made o f stainless steel as a conducting 
surface, and insulating components (machinable glass, Teflon, ceramic, or other 
plastics) [23]. The electric field in a drift tube is provided by a high voltage supply 
(typically ±1-10 kV). Electric pulses are applied to an ion shutter to create multiple ion 
mobility spectra.
The ionization source, normally housed in the reaction region o f the drift tube, 
must be insensitive to oxygen, moisture, and other components o f sampled air. 
Ionization methods include use o f radioactive sources, photoionization, corona-spray
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Fig. 2. Schematic of the Barringer IONSCAN 400 [24]
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ionization, flame ionization, and corona discharge [1]. A very common detection 
method to measure ion current utilizes a circular collector plate.
Chemistry. There are two major chemical processes in IMS analysis. The first 
is the gas-phase ionization of target analyte molecules through charge exchanges or 
ion-molecule reactions at atmospheric pressure [1]. The second is analyte ion mobility 
in a weak electric field.
Target molecules are ionized by either proton-transfer reactions (Equation 1), 
and negative ion reactions such as ion transfer (Equation 2), charge transfer (Equation 
3). or dissociative charge transfer (Equation 4) [1].
T + H(H20 )n — > TFT + nH20 ; n =1-3 (1)
T + (H20 )n0 2' - — > T *02' + nH20 ; n = 1-3 (2)
T + (H20 )n0 2‘ ----- > T  + 0 2 + nH20 O)
T-X + (H20 )n0 2' ----- > X + T + 0 2 + H20 (4)
During the chemical ionization, other reactions, such as nucleophilic attachment 
and hydride abstractions may also occur. The ion clusters shown in equations 1 -4 are 
formed from ambient air in a series of reactions initiated by beta particles when Ni63 is 
the ionization source.
If nicotinamide is chosen as a reagent molecule to increase selectivity, 
protonated nicotinamide may react with the target analyte (Equation 5 and 6).
(H20)nH+ + Nicotinamide ----- >  (H20 )n(Nicotinamide)H+ (5)
(H20)n(Nicotinamide)I-r + T  >  TIT + nH20 + Nicotinamide (6)
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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The product ions that are formed through these processes are generally long- 
lived. robust, and low energy species. Also, since they rarely dissociate or fragment, 
they can be related directly to the original neutral molecule [1]. There is preferential 
and competitive distribution o f the available charge among neutral molecules in the 
sample according to their gas-phase electron or proton affinities. Selectivity of IMS 
for different analytes is based on the atmospheric pressure ionization events themselves, 
the polarity of the ions and the mobility of the ions. Target analytes with high electron 
or proton affinities can be detected more readily than those with low affinities. The 
ionization chemistry can be modified through the use o f specific reaction ions such as 
protonated nicotinamide mentioned above.
After the target molecules are ionized, they are differentiated according to their 
gas-phase mobilities. These are calculated from drift time across a fixed distance in an 
electric field. Mobility is related to the electric field strength by the ion drift velocity. 
The drift velocity (vd) (Equation 7) is inversely proportional to drift time and is 
calculated from the mobility (K) and electric field (E) [23].
vd = K •  E (7)
In most cases, product ion migration is related to reduced mobility constant, Ko 
(cnr/V ' s 1), which is K expressed under standard temperature and pressure conditions. 
(Equation 8)
Ko = _L_*273 • 760 (8)
tdE T P
Where,
L = length o f ion drift region (cm)
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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t<i = drift time (s)
E = electric field strength (V/cm)
T = temperature (K.)
P = pressure (torr)
Target analytes with product ions o f different masses can be differentiated very readily 
through drift times (different mobility constants). The signal amplitude can be used as a 
basis for semiquantitative or quantitative analyses, depending on how carefully the 
conditions are controlled.
The method chosen to ionize target molecules could affect the mobility 
spectrum of compounds due to differences in ionization chemistry. The use o f 63Ni has 
been popular due to its physical stability; instruments have been produced with noise- 
free operation, low power demands, small size, cost effectiveness, and capability to 
operate in explosive atmospheres [1]. Although the use o f 63Ni is still common, other 
ionization techniques are gaining popularity. Photoionization represents an interesting 
alternative with added selectivity and a large linear working range. Selectivity can be 
tuned through the use o f photodischarge lamps with different ionization energies. 
Corona-discharge is another method currently being investigated, which allows a broad 
range of organic compounds to be ionized [25]. Alternatives to radioactive ionization 
sources are being investigated by several research groups.
It is possible to control the ion chemistry, through the selection o f different 
ionization sources as well as reactant ions. This should lead to much higher sensitivity 
and selectivity, and more quantitative results. It should help to better focus IMS toward 
specific scenarios in applications such as clinical chemistry.
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State o f  the Technology in Clinical Chemistry
Clinical chemistry encompasses various bioanalytical techniques used to 
diagnose medical disorders. This branch of laboratory medicine includes, but is not 
limited to, the assessment o f the endocrine system, acid-base balance, hematology, and 
renal, liver, gastric, pancreatic and intestinal functions. It also incorporates many 
aspects of pathophysiology, chemistry, statistics, instrumental analysis, as well as 
principles of quality control and management. Clinical chemistry has become a vital 
part of health care management, and continues to be used by medical technologists and 
practicing physicians.
Clinical laboratories rely heavily on automated instrumental analysis and require 
strict quality control management. Chemical analyses of tissues and body fluids are 
performed to elucidate molecular interactions and pathways, and to verify different 
diseases. Major techniques used in today's clinical laboratories are listed in Table 2.
Table 2
Examples of techniques utilized in clinical laboratories [26]
Clinical Chemistry Departments Automated Analysis
General Chemistry Immunoassay
Immunoassay Chemiluminescence and bioluminescence assays
Off-site Automation High-performance liquid chromatography (HPLC)
Hematology Capillary electrophoresis
Microbiology Electroanalysis and biosensors
Urinalysis Flame, flameless, and plasma spectroscopy
Blood Bank Mass spectrometry
Reference Infrared spectroscopy
Clinical instruments for general chemistry integrate sample processing, chemical 
analyses, and data management as part o f total laboratory automation. Emphasis is
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placed on cost effectiveness and efficiency with expanded menus o f assays. There is a 
new focus of combining measurement techniques such as traditional chemistry 
(electrolyte assays, enzymatic assays, etc.) and immunoassays in a single analyzer. This 
type of analyzer may utilize robotics and data management to form an integrated system 
[26]. Efficiency of immunoassay analyzers may be enhanced by long-term calibration, 
autodilution, barcoding, stat and repeat capabilities, and clot detection. The current 
trend is toward modular automation, where two or more instruments are linked by a 
single controller, with additional instruments added as needed. In this scenario, 
analyzers share sample and reagent handling preparation, and transport systems.
Another trend is toward bedside analysis whenever possible. Thus, there is an increased 
interest in on-site automation and the development of miniature analytical devices, 
microchips, and microscopic channels. Disposable devices that eliminate the 
manipulation of manual reagents offer convenience, quality assurance, rapid results, and 
cost effectiveness [26].
Some clinical analyzers include test panels for a comprehensive blood analysis, 
consisting of white cell, hemoglobin, red cell, and platelet counts. There is an increased 
interest in limiting manual review for cell counting. Advances have been made in 
automated slide markers, scanning devices, and image analysis. There have been 
several advances in molecular diagnostics for the detection o f infectious diseases. 
Amplification methods in microbiology and virus testing have been enhanced through 
polymerase chain reactions (PCR), ligase chain reactions (LCR) and nucleic acid-based 
sequence amplification (NASBA) [26]. These techniques are available for a variety of
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organisms and offer increased sensitivity and turn-around time when compared to 
culture-based or other direct immunologic methods.
Among the instruments in the clinical laboratory, are those dedicated for specific 
analytes, such as in urinalysis and blood bank analyses. Often these tests are handled in 
individual departments to increase quality control. In addition, there are reference 
laboratories that perform non-routine assays or offer specialized techniques.
Immunoassays utilize antibodies or antibody-related reagents for the 
determination o f specific analytes. The use of antibodies allows very high selectivity, 
though some cross-reactivity may be encountered. Immunoassays, as categorized by 
the labels employed, include radioimmunoassays (RIA), enzyme immunoassays 
(ELISA), fluoresence immunoassays (FPIA), and chemiluminescence immunoassays 
(CIA). Other immunoassay variations include nonlabeled, electrochemical, liposome, 
chromatographic, and elcetrophoretic techniques [26].
Methods based on chemiluminescence and bioluminescence utilize light 
emission to label compounds in the analysis o f body fluids and tissues. Light is 
produced from the decay o f excited species to electronic ground states in chemical 
reactions, and from reactions utilizing materials of biological origin. Such techniques 
are used to analyze DNA, iron (III) in blood, hormones, and nitric oxide in exhaled air 
from patients with lung cancer, and hormones, among others [26]. Chemiluminescence 
has become a routine technique in the clinical laboratory. The use o f bioluminescence, 
light emission with biomolecules, is increasing.
Electrophoresis carried out in a small-bore fused silica capillary is termed 
capillary electrophoresis [27]. Clinical laboratories routinely use this method to assist in
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diagnosing disorders such as arthritis, phenylketonuria, organic acidurias, and 
neuropsychiatric diseases. Capillary electrophoresis is also used in DNA and RNA 
analysis, drug monitoring, protein analysis, and single-cell analysis [28].
High-performance liquid chromatography (HPLC) can be used to measure many 
of the analytes mentioned above, although it is utilized mainly as a confirmatory 
method in clinical chemistry. HPLC is also used to detect markers in diagnosis, 
treatment and prognosis o f diseases. HPLC may be coupled to mass spectrometry (MS) 
and nuclear magnetic resonance (NMR) to increase reliability in the identification of 
bioanalytes [26].
The trend in analytical chemistry toward miniaturization extends to clinical 
chemistry as well. This includes research and development on genosensors (gene-based 
detectors), enzyme electrodes, biocatalytic and affinity biosensors, immunosensors, 
DNA biosensors, optical sensors, ion selective electrode, and voltammetric and 
amperometric devices [29,30].
Many clinical laboratories use MS to identify the molecular composition and 
structure of bioanalytes. This includes electrospray ionization (El) and matrix-assisted 
laser desorption/ionization (MALDI) techniques. MS may also be coupled with other 
methods such as GC and HPLC to provide very rigorous and reliable analysis. Such 
combinations are used in illicit drug and metabolite analyses, and in complicated tasks 
such as protein characterization, sequencing o f DNA, quantification o f disease markers, 
and detection of genetic mutations [31,32].
Flame, flameless, and plasma spectroscopy are used primarily for the analysis of 
metals in biological specimens. Flame atomic absorption is relatively simple and is
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used for the determination o f  metals such as lead, copper, iron, manganese, and zinc at 
ng/mL levels [33]. Flameless atomic absorption techniques have been transitioned from 
the laboratory to the bedside with the development o f portable analyzers. The target 
analytes are chromium, cadmium, and magnesium [34]. Inductively coupled plasma 
atomic emission spectrometry (ICP-AES) and ICP-MS are powerful tools which can be 
used for multielement determination, although high cost is a limitation [26].
Infrared (IR) spectroscopy may be useful in organic structure determination in 
specific clinical scenarios such as in diagnosing liver disease, monitoring cancer 
progression, and monitoring oxy- and deoxyhemoglobin in the brain, blood, and other 
tissues [26].
Selecting Instruments for the Clinical Laboratory. The clinical laboratory 
represents a dynamic environment in which measurement technologies are continually 
being updated and new methods are being introduced [35]. As dictated by new 
advances in medical sciences, needs for higher sensitivity, increased selectivity, cost 
effectiveness, and rapid response are increasing.
Information on selecting instruments for clinical chemistry is available [36]. 
Table 3 was compiled to illustrate some o f the important considerations. Clinical- 
specific requirements based on the chemistry and biochemistry needs would fall under 
performance objectives.
As mentioned earlier, IMS technology has proven itself in many applications not 
directly related to clinical chemistry. IMS has been chosen over other technologies 
because of its unique advantages. This thesis addresses the question of IMS relevance 
to current and evolving needs in the clinical laboratory.
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Table 3






Analysis time per sample 
Sample throughput 
Preventive maintenance costs 
Service contract costs 
Service call costs
QA/QC
Ability to meet/exceed data quality objectives 
Performance
Ability to meet performance objectives 
Minimization of interferences 





Availability of vendor training 




Capability to flag anomalies
Selectable tests for profiling
Multisample capability
Adequacy of sample identification system
Adequacy of reports










Statements of Hypotheses and Specific Aims
The major goal is to examine IMS as a rapid screening tool for specific 
application to clinical chemistry research and clinical laboratory use. Methodology will 
be developed for target analytes representing several classes o f  physiologically active 
substances. Emphasis will be placed on potential interferences and quantification of 
data. IMS characteristics o f animal tissues, amino acids and proteins will be 
determined. Information will be obtained on potential interactions between selected 
physiologically active substances and other molecules. The research is meant to 
narrow the gap between clinical chemistry needs fo r  a rapid, inexpensive, easy-to-use 
analytical technique and the high potential o f  IMS to meet those needs.
Our hypotheses and specific aims are as follows:
Hypothesis 1: We hypothesize that quality assurance and quality control 
procedures for IMS use in the clinical laboratory and clinical chemistry research 
can be established. The specific aim is to perform background checks and 
calibration curves from controlled standards, thus establishing criteria for 
assessing the accuracy o f data.
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Hypothesis 2: We hypothesize that IMS can be used to analyze materials of 
biological origin in clinical chemistry. The specific aim is to analyze plasma 
and tissues harvested from rabbits and to determine whether the potential exists 
to characterize them using IMS.
Hypothesis 3: We hypothesize that information useful to clinical chemistry can 
be obtained from a data compendium of IMS mobility spectra and associated 
reduced mobility constants o f compounds related to biological materials can be 
compiled. The specific aim is to illustrate potential utility o f IMS information 
through a compilation o f IMS data from a variety o f substances including animal 
tissue, drugs, proteins, amino acids, as a few examples.
Hypothesis 4: We hypothesize that IMS can be used to characterize a variety o f 
physiologically active chemicals in biological media. The specific aim is to 
identify anesthetics and drugs in rabbit tissues and plasma as a demonstration of 
the vast analytical potential of IMS in such applications.
Hypothesis 5: We hypothesize that there may be enhancement and retardation 
effects that affect the utility o f IMS in clinical chemistry. The specific aim is to 
identify such anomalies using the IMS of cocaine, heroin, and several of their 
metabolites as an illustration of what might be encountered in the clinical 
laboratory, and in clinical chemistry research.
Hypothesis 6: We hypothesize that guidelines can be formulated relative to the 
use of IMS for clinical chemistry. The specific aim is to assess the advantages 
and disadvantages o f IMS use in a clinical chemistry setting based on the thesis 
research.
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There are many areas can be explored relative to the viability o f  IMS in the 
clinical laboratory. However, it is judged that the research as outlined above will form 
a sufficient information base to allow both researchers and developers to make 
decisions on whether to pursue IMS in clinical chemistry applications.





The research designs and methods for this project focus on the development of 
procedures to analyze biological materials and physiologically active substances using 
IMS. while seeking quality results. Quality assurance issues are addressed in the next 
chapter, but are implemented throughout the experimental protocol covered here.
The experimental design incorporates IMS in the analysis o f various animal 
tissues for the detection o f physiologically active substances introduced in vitro and in 
vivo. It should be noted that the IMS of animal tissues has not been reported in the 
literature. The IMS measurement methods were adapted from well-known IMS 
techniques utilizing solid samples. Though improvements are envisioned, the 
techniques described here are judged to be sufficient for the data quality objectives of 
the thesis and illustrate how easily IMS can be adapted.
The Barringer IONSCAN 400 IMS was available for this research and 
represents technology which is well proven in the field and ports of entry for illicit 
substances, both drugs and explosives.
The use of biological materials in the research represents a partnership between 
the Department o f Biological Sciences, and the Department o f Chemistry and 
Biochemistry at Old Dominion University.
The Old Dominion University Chemical Hygiene Plan was followed.
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Instrumentation
Barringer IONSCAN ion mobility spectrometer, Model 400 settings were as 
follows for the positive mode: analysis time - 8 seconds; drift tube: 233 °C; inlet:
275 °C: and desorber: 288 °C. For negative mode studies, the settings were: analysis 
time: 6.4 seconds; drift tube: 105 °C; inlet: 237 °C; and desorber: 247 °C. The sample 
membranes were Barringer Teflon™, 50 pm pore size. The instrument software allows 
calculation of peak amplitudes as either maximum, cumulative, or average values. 
Average amplitudes were utilized throughout for the calibration curves and 
semiquantitative analyses.
Animal Tissues
Subsections below detail the surgical procedures that were used by 
co-investigators to harvest animal tissues. The tissue storage and handling procedures 
employed are standard, and were supervised by Dr. Barbara Hargrave in the Old 
Dominion University Biological Sciences Department.
Animals and Materials
Male and female New Zealand White rabbits were purchased from Blue and 
Gray Rabbitry, Unionville, VA. Rompun (100 mg/mL xylazine, 0.9 mg methylparaben, 
0.1 mg propylparaben) was obtained in aqueous solution at pH of 5.5±0.3. Citric acid 
and sodium citrate were added for pH adjustment. Ketaset (100 mg/mL ketamine HC1 
and 0.1 mg/mL benzethonium chloride) was obtained in water (pH 3.5-5.5). Rompun 
(5 mg/kg) and Ketaset (40 mg/kg) were used to induce general anesthesia during 
surgical procedures. A pentobarbital solution (324 mg/mL) was used as the
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euthanizing agent. The above drugs were purchased from Henry Schein Port 
Washington. NY. Heparin sodium (1000 units/mL), purchased from Eikins-Sinn Inc., 
Cherry Hill, NJ. was used for intravenous or intraarterial injections as an anticoagulant. 
Heparinized saline ( 8.6 mg sodium chloride, 0.01 mL benzyl alcohol in water at pH 5.0 
-  7.5; NaOH and/or HC1 were added to adjust pH) was also used as an anticoagulation 
agent. Heparinized saline was placed in all catheters before and after obtaining blood 
samples.
Surgical Procedures
Each rabbit was fasted 12 hours prior to surgery and had free access to water 
(protocol approved by the Animal Care and Use Committee, Old Dominion University). 
The intramuscular administration of Ketaset and Rompun induced general anesthesia.
A polyvinyl catheter, containing heparinized saline, was placed in the carotid artery.
The heparin-saline filled catheter was closed and run subcutaneously through the nape 
of the neck. All incisions were sutured and the catheter was placed in a polyvinyl 
pouch and sewn to the nape o f the neck for protection against accidental removal. Each 
rabbit was allowed at least 24 hours to recover from surgery before experiments. All 
animals were housed in individual cages, and allowed free access to food and water. It 
should be noted that the animals were used by Dr. Hargrave for physiological 
measurements which are not part of the thesis research. Those results are not reported 
here. An example is a thesis by Andrea Chambliss [35].
On the day of an experiment, the rabbits were allowed to acclimate to their 
surroundings for approximately 60 minutes. The catheter was opened and filled with a 
solution of fresh heparinized saline. Each rabbit was then given an intra-arterial
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injection of saline (1 mL), heroin (200 pg), or ecgonine methyl ester (EME) (2 mg/kg). 
Acute as well as chronic studies were performed. In acute studies, arterial blood 
samples were taken five and thirty minutes after the drug is injected. In chronic studies, 
the drug was administered on a timed device for 14 days via an Alzet pump. After the 
completion of each experiment, pentobarbital (1 mL) was administered to euthanize the 
animal. Adult rabbit liver, lungs, kidneys, renal arteries, heart, ovaries, and testicles 
were removed and placed in appropriately labeled sterile tubes. The tissues were then 
placed into sterilized containers and snap-frozen with liquid nitrogen. All tissues were 
stored at -70°C until analysis. Samples o f fetal liver, lungs, kidney, and heart were also 
removed, pooled, and frozen with liquid nitrogen and stored under the same conditions. 
Designation numbers and information concerning each animal are given in Table 4. 
Tissue Preparation
To prepare tissue samples for analysis by IMS, a fraction o f adult and fetal 
tissues were thawed and dried using a speed vac centrifuge. After the tissue was dried, 
samples were ground into a powder using a mortar and pestle. Each sample was labeled 
with the appropriate animal number, date, and tissue type.
Procedures fo r In Vitro Studies
Tissue samples were stored in a refrigerator until the day o f  IMS analysis.
Small amounts of dried tissue from rabbits given the saline control were weighed and 
analyzed by IMS to establish a control background. The Teflon membranes were pre­
cleaned by analyzing each separately with the IMS until there were no peaks present 
other than the reactant ion peak. Approximately 0.5-1 mg o f dried tissue from the 
organs (liver, lungs, kidneys, renal arteries, heart, and ovaries) of animals receiving
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Classification o f experimental conditions for each control animal, which received 




















3.3 Ketaset and 
Rompun
none
C4 acute pregnant 4.0 none used
A27 acute pregnant 3.8 Ketaset and 
Rompun
none
A43 acute pregnant 4.2 Ketaset and 
Rompun
used
A44 acute pregnant 4.6 Ketaset and 
Rompun
used
A3 9 chronic pregnant 5.8 Ketaset and 
Rompun
used
A40 chronic pregnant 4.1 Ketaset and 
Rompun
used
saline, heroin or EME was placed on Teflon membranes for IMS analysis. This 
procedure was performed to indicate the presence or absence of each drug or its 
metabolites. All samples were analyzed in the positive ion mode by IMS, with selected 
samples being analyzed in the negative ion mode.
In order to optimize the IMS experimental protocol used to evaluate each animal 
tissue, 0.5-1 mg of C3 brain tissue samples (harvested from a rabbit exposed to 
heparinized saline) were individually analyzed on pre-cleaned Teflon membrane at 
varying desorber temperatures and sampling times. The desorber temperature of the 
IMS was reprogrammed from the standard temperature of 288°C to 100°C, 150°C,
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200°C. 250°C and 300°C during analyses. The sampling time was also changed from an 
8 second analysis to 5, 10, 15, and 20 second analyses.
Aliquots of several concentrations o f different drugs were added directly to 
various tissues to assess potential interactions between the tissues and each drug. 
(Procedures for each drug class are given below under the name o f each drug.) The 




Amino acids were analyzed using both positive and negative modes o f the IMS. 
This allowed fingerprints for each amino acid to be established. Compounds included 
glycine, phenylalanine, tryptophan, glutamine, tyrosine, cysteine, arginine, histidine, 
and glutamic acid. Prescreening involved placing small amounts on Teflon membranes 
and analyzing with IMS. The amino acids that had distinct IMS signatures were 
selected for further analysis.
Small amounts (approximately 0.5-1.0 mg) of each amino acid was placed on a 
pre-cleaned Teflon membrane and analyzed under standard conditions. The two amino 
acids (tyrosine and glutamine) with prominent signatures were also analyzed on S&S 
paper (Schleicher and Schuell, 6.2 cm diameter) and QMA (Whatman glass microfiber 
filters, 4.7 cm diameter). Solutions o f tyrosine were made by dissolving 10 mg of 
tyrosine in 9 mL of water and 1 mL of HC1 (11.6 N). Diluting with 5 mL water and 5 
mL methanol gave concentrations o f 1000 ng/pL and 100 ng/pL. One pL of each 
tyrosine solution was placed on S&S paper and QMA and analyzed in both the positive
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and negative modes. A similar procedure was employed in making glutamine solutions 
and obtaining IMS mobility spectra. The amino acids were tested with analytes using 
the same procedures as with proteins mentioned below.
Proteins
Vegetable protein powder (Sundown, 94%), containing calcium, phosphorus, 
iron, magnesium, and an amino acid profile, were evaluated for effects on the IMS of 
heroin and its metabolites. Small amounts o f solid were analyzed with and without 
analyte. Aliquots o f various concentrations o f heroin were applied directly to the amino 
acid or protein. The solvent was allowed to evaporate for approximately 1 minute and 
the mixture was analyzed for any noticeable differences.
An IMS background of vegetable protein was obtained by placing 0.5-1 mg o f 
protein powder on a Teflon membrane and analyzing it in the positive mode o f IMS.
The analytes. 100 ng o f heroin HC1 in methanol, 25 ng of morphine in methanol, and 25 
ng of 6-acetylmorphine in acetonitrile, were pipetted directly onto 0.5-1 mg o f protein 
powder and analyzed. Also, adding 25 ng, 50 ng, 75 ng and 100 ng o f heroin solution 
onto individual Teflon membranes with 0.5-1 mg of vegetable protein allowed a 
calibration curve for heroin in the presence of protein powder to be obtained. Triplicate 
analyses were performed.
Glycine Peptides
Glycine peptides (Sigma Chemical Co.) were investigated for their IMS 
properties and effects on the IMS o f heroin. Specifically, diglycine, triglycine, 
tetraglycine, pentaglycine, and hexaglycine peptides were analyzed to determine if the
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number of repeating units made a difference in the results. In addition, polyglycine 
peptides of molecular weights 4,600 and 5,200 were evaluated.
A background o f each glycine peptide was obtained by placing 0.5-1 mg o f the 
solid on a Teflon membrane and analyzing with IMS. Solutions o f 25 ng and 50 ng o f 
heroin-HCl in methanol were placed directly onto each peptide powder. The solvent 
was allowed to evaporate for approximately 1 minute and the sample was scanned in 
the positive mode. Experiments were performed in triplicate. Significant changes in 
the peak height of heroin were recorded.
Rompun and Ketaset
Both Rompun (5 mg/kg) and Ketaset (40 mg/kg) were administered to the New 
Zealand White rabbits to induce general anesthesia during surgical procedures. These 
compounds were also examined by IMS in both the positive and negative modes to for 
control purposes. Calibration curves for each anesthetic were obtained using 
methanolic solutions. A stock solution of 100 ng/pL was prepared by adding 495 pL o f 
methanol to 5 pL o f anesthetic solutions received, with subsequent dilutions to 50 
ng/pL. 25 ng/pL, 10 ng/pL, 5 ng/pL, and 1 ng/pL concentration levels. IMS analyses 
were performed using pre-cleaned Teflon membranes.
Tissues harvested from rabbits that received injections of Rompun and Ketaset 
were analyzed for xylazine and ketamine, respectively. This was done to determine if 
these anesthetic agents could be detected in tissues using IMS. Other studies included 
the deposition (via syringe) o f 100 ng/pL of Rompun or Ketaset directly on tissue from 
the heart, liver, lungs, kidney, renal arteries, and ovaries o f  control animal C3, who
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received only pentabarbitol. This helped to confirm that IMS peaks assigned to the 
anesthetic from in vivo tissue correlate with the same peaks from in vitro studies.
An extraction study was also performed to determine if  anesthetics could be 
extracted from tissues harvested from animals exposed to Rompun and Ketaset. 
Representative samples of 50 mg — 70 mg o f atrial. lung and ventricle C3 animal tissue 
were placed into vials of 1 mL with methanol or 1 mL of acetonitrile. These samples 
were shaken and allowed to stand in a refrigerator overnight. The supernatant liquid 
was decanted the next day and allowed to warm to room temperature. Five pL o f the 
supernatant were allowed to evaporate on a  pre-cleaned Teflon membrane using 
standard conditions, and analyzed by IMS. The solvent was allowed to evaporate from 
the remaining tissue samples at room temperature and residues were also analyzed.
The euthanizing agent was composed of pentobarbital sodium, isopropyl 
alcohol, propylene glycol, edetate disodium, and benzyl alcohol. The euthanizing agent 
and benzyl alcohol (Mallinckrodt Chemical Co.) were checked for potential IMS 
signatures. A heparin sodium solution (1000 USP units/mL) was also used in the 
surgical protocol for each animal. One pL o f this solution was analyzed to detect any 
IMS signature.
2-Chloroethyl Ethyl Sulfide and Methyl Iodide
Stock solutions of 2-chloroethyI ethyl sulfide (1 mg/mL) were prepared by 
adding 2 pL of the neat chemical to 2 mL o f acetonitrile. Dilutions were made to 100 
ng/pL and 500 ng/pL. Analyses were performed in negative and positive modes using 
Teflon membranes. The negative mode was chosen for tissue studies because o f the 
more prominent signature. Aliquots o f each concentration of the analyte were added to
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C3 brain tissues previously lyophilized and ground. The mixture was analyzed by IMS 
to determine any changes or interactions between the tissue and 2-chloroethyI ethyl 
sulfide. Each concentration o f 2-chloroethyl ethyl sulfide was also added to 100 ng/pL 
of Rompun and 5 ng/pL of cocaine to examine any potential interactions between 
compounds. Methyl iodide (99%), another alkylating agent, was also examined in a 
similar manner. Aliquots (1 pL and 5 pL amounts) of neat compound were examined 
in negative and positive IMS modes. Methyl iodide solutions were added to 0.5-1 mg 
of C3 brain tissue and 100 ng/mL of Rompun followed by IMS analysis to detect any 
potential interaction.
Identification of Factors that Influence the IMS Analysis of Contraband Drugs
Reagents
Anhydroecgonine methyl ester (AEME) standard in acetonitrile (1.0 mg/mL) -  
Radian International, 99% purity; ecgonine methyl ester (EME) standard in acetonitrile 
(100 pg/mL) -  Radian International, 99% purity; heroin hydrochloride standard in 
methanol (100 pg/mL) — Sigma Chemical Co.; 6-acetylmorphine standard in 
acetonitrile (1.0 mg/mL) - Radian International, 99% purity; cocaine hydrochloride 
standard in methanol (1.0 mg/mL) — Sigma Chemical Co.; morphine; cocaethylene; 
codeine; ecgonine hydrochloride standard in methanol (1.0 mg/mL) — Radian 
International; benzoylecgonine standard -  Radian International.
Cocaine Hydrochloride and its Decomposition Products
Two studies were performed to determine effects that cocaine decomposition 
products might have on the IMS characteristics o f cocaine. In one study, IMS was used
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for the identification and analysis of AEME and EME in the presence o f each other. The 
second study involved the analysis of cocaine in the presence o f AEME alone.
AEME and EME exhibit ion mobility values which are relatively close (reduced 
mobility constants, Ko: 1.505 and 1.485 c m V 's '1, respectively). Calibration curves 
were obtained using 1 pL each of acetonitrile solutions: 0.2, 0.5. 1,5, 10, 25, 40, 50, 
and 100 ng/pL (AEME) and 0.5, 1,5, 10, 20, 25, 30, 40, 50, and 100 ng/pL (EME).
The aliquots were applied individually to Teflon membranes using a 1 pL syringe. The 
syringe was cleaned before each deposition first with acetonitrile or methanol, then with 
the particular test solution. In each deposition, the solution was spread evenly on the 
membrane with the tip o f the syringe needle. The solvent was allowed to evaporate for 
approximately one minute before the IMS analysis. The IMS analysis was repeated, 
usually one or two times, until no residual sample was detected on the membrane. 
Though all results were recorded, only results from the first run were used for the 
calibration curve. Each sample was analyzed in triplicate.
AEME/mL acetonitrile (100 pg), EME/mL acetonitrile (100 pg), and acetonitile
Tt|
were pipetted (Eppendorf ‘ pipettes) into vials making up solution volumes of 100 pL 
in testing IMS response with mixtures. The ratios by weight (AEME/EME) for 
individual samples were: 10 ng/10 ng, 10 ng/20 ng, 10 ng/40 ng, 10 ng/60 ng, 10 ng/80 
ng. 20 ng/10 ng, 40 ng/10 ng, and 60 ng/10 ng. After each solution was applied to the 
Teflon membrane, the solvent was allowed to evaporate before analysis.
To determine the effects of AEME on cocaine hydrochloride, calibration curves 
were established for each compound. Aliquots o f cocaine solutions with 1 ng/pL, 5 
ng/pL, 10 ng/pL, 15 ng/pL, 30 ng/pL, 50 ng/pL, 75 ng/pL, and 100 ng/pL
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concentrations were prepared in methanol and analyzed by IMS in the positive mode. 
AEME calibration concentrations o f 0.2 ng/pL, 0.5 ng/pL, 1 ng/pL, 5 ng/pL, 10 ng/pL, 
25 ng/pL, 50 ng/pL, 75 ng/pL, and 100 ng/pL were prepared in acetonitrile and 
analyzed. Ratios o f 10:1, 10:5, 5:1, 5:5. 5:1, 0.2:5, 0.5:5, 1:5, 1:1. 1:10, and 1:25 of 
AEME to cocaine-HCl were also analyzed. Aliquots of both compounds were applied 
to a pre-cleaned Teflon membrane one after another, with AEME being applied after 
cocaine-HCl. The order o f addition was important. Other compounds, such as 25 
ng/pL benzoylecgonine, 25 ng/pL codeine, 25 ng/pL cocaethylene. 25 ng/pL 6- 
acetylmorphine. 25 ng/pL morphine, 25 ng/pL ecgonine, 25 ng/pL heroin and 25 ng/ 
pL EME were also analyzed in the presence o f cocaine to determine their effects, if  any. 
In addition, a 10:5 ratio o f cocaine HC1 to AEME were examined on surfaces o f S&S 
paper, QMA. Whatman filter paper, and Barringer, 3.0 cm diameter fiber glass filters in 
lieu o f Teflon membranes, to determine any matrix effects in the desorption process. 
Heroin and its Metabolites
The effects o f 6-acetylmorphine on the IMS detection o f heroin were examined. 
Aliquots of heroin hydrochloride were applied to a Teflon membrane. This was 
followed with aliquots o f 6-acetylmorphine in various concentrations. Studies with 
various mixtures o f 6-acetylmorphine and heroin hydrochloride were analyzed. The 
solvent was allowed to evaporate prior to analysis. Each analysis was performed in 
triplicate.
The analysis of heroin hydrochloride and 6-acety 1-morphine by IMS was 
accomplished by applying 1 pL aliquots o f heroin hydrochloride to Teflon membranes 
using microcapillary pipettes followed by aliquots of solutions containing different
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amounts o f 6-acetylmorphine. Each solution was spread evenly on the membranes 
using the tip o f the microcapillary pipette. The solvent was allowed to evaporate prior 
to analysis. The heroin hydrochloride methanolic solutions contained 25 ng, 50 ng, 75 
ng or 100 ng heroin freebase per pL. Each amount o f heroin was analyzed in the 
presence of 25 ng, 50 ng, 75 ng and 100 ng of 6-acetylmorphine. These amounts o f 6- 
acetylmorphine were contained in 1 pL, 2 pL, 3 pL, and 2 pL acetonitrile solutions, 
respectively. Each combination was analyzed in triplicate.
To evaluate the interaction of opiates on animal tissues, 25 ng/pL and 100 ng/pL 
heroin-HCl, 25 ng/pL 6-acetylmorphine, and 25 ng/pL morphine were added in vitro to 
0.5-1 mg A39 brain tissue. Each sample was weighed on pre-cleaned Teflon. One pL 
aliquots of each opiate were added individually to each tissue. The samples were then 
analyzed in the positive mode using IMS.
GC/ MS of Animal Tissues Exposed to Heroin
Gas chromatography-mass spectrometry (GC-MS) was used to analyze samples 
of animal tissues exposed to heroin in vivo and in vitro, as well as each separately to 
assist in understanding interactions with animal tissues. A gas chromatograph (Hewlett 
Packard model HP-3840) coupled with a quadrapoie mass spectrometer was used in the 
experiments. The capillary column was J&W DB-5 column (30 m, 0.25 mm I.D., 0.25 
pm film thickness). The temperature of the injection port was 250°C and the 
temperature o f the oven was programmed: 50°C held for 1 minute, then ramped with 3 
steps: 50°C/minutes to 200°C held 3 minutes, 20°C/min to 250°C held 2 minutes, 
20°C/min to 300°C held 3 minutes. Helium was used as a carrier gas with a constant 
pressure o f 12 for the chromatographic process. A purge time to vent was set for 0.75
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minutes to allow a complete desorption of analytes. Aliquots of 10 ng, 100 ng, and 
1000 ng of heroin-HCl in methanol were manually introduced to the split/splitless 
injection port of the GC-MS with a 10 pL syringe. Small amounts (0.5-1 mg) o f animal 
tissue were analyzed by placing the tissue in a deactivated GC liner. Silanized glass 
wool was placed at both ends of the liner to prevent any of the solid particles from 
entering the column.
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CHAPTER III 
ION MOBILITY SPECTROMETRY QUALITY ASSURANCE AND 
QUALITY CONTROL
Introduction
Quality assurance and quality control (QA/QC) procedures are necessary to 
ensure that the IMS data generated are as precise and accurate as possible. Such 
procedures assist in the daily monitoring of instrument performance, providing an early 
indication o f potential problems, as well as keeping maintenance records up to date for 
any necessary corrective actions. QA is a system of activities required to provide the 
quality of data needed. High quality in one situation may be unacceptable in another.
QC procedures ensure the quality and integrity o f the data [36]. QC refers to the actual 
procedures employed to ensure that the data generated is accurate and precise enough for 
its intended use. Although the QC protocol may be similar using a particular technology 
such as IMS. the overall QA plans may differ depending on the data quality objectives. 
The plans implemented in clinical chemistry incorporate extra measures to ensure data 
accuracy.
A QA/QC program measures and verifies laboratory performance, while 
generating accurate and precise data. Accuracy is the indication of closeness of 
agreement between an observed value and the true value, while precision is the 
expression of the reproducibility o f the value [37]. Basic elements o f QA/QC include 
suitable equipment, good laboratory and measurement practices, standard operations 
procedures, documentation, and training. To assess the efficacy of a QA/QC plan, 
internal and external assessment techniques may be utilized. The repetition of
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measurements, control charts, measurements using different instruments, and the 
interchange of operators is an example of internal techniques. External techniques may 
involve analyzing standard reference material and collaborative tests with other 
laboratories [36].
The quality needed for the data obtained in the present research varied with each 
study. In experiments involving animal tissues and biologically related materials, the 
emphasis was more on qualitative aspects rather than quantitative assessment. In the 
identification of factors that influence the IMS of contraband drugs, more importance 
was placed on the semi-quantitative analysis o f the data obtained. Instrument 
performance was also monitored very closely to ensure quality data throughout.
The quality control plan in most clinical laboratories incorporates the practices 
mentioned above, but may include extra measures to ensure that data quality objects are 
met. In many cases, physicians base their diagnoses heavily on the laboratory results. 
Measures, such as delta checks, are examples of quality control procedures to ensure the 
integrity of the data. Delta checks are performed by comparing values from previous 
specimen from the same patient with current results and determining if they are 
significantly different (by 15%). Proficiency testing utilizes external quality control 
samples, which allows the performance o f different laboratories to be followed for long­
term accuracy of analytical results [38]. The thesis research did not address any specific 
clinical laboratory need, but focused on obtaining the best IMS data possible under the 
constraints of specific experiments.
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Quality Control Procedures
Specific QC procedures that may be implemented include instrument calibration, 
the analysis of reference standards, replicates and blanks. Also included are sample 
handling and preparation, complete documentation, proper data generation, and 
corrective actions for factors which might adversely affect the quality o f the data.
The components of the QC protocol used for generating IMS data in this thesis 
included [37]:
> Analyzing a QC standard at both the beginning and end o f a day’s analyses.
> Obtaining daily 3 point calibration curves and comparing results to the most
recent and more extensive curve for target analytes when data is to be used in a
semi-quantitative analyses.
> Maintaining a laboratory standard log which contains information on all
quality control maintenance and calibration standards.
> Adhering to a regular instrument maintenance schedule.
Preparation o f Quality Control Standards.
Cocaine hydrochloride standards (for the positive IMS mode) and 2.4,6- 
trinitrotoluene (TNT) (purchased from Radian) (for the negative IMS mode) were 
prepared in methanol from certified standards available commercially. The QC 
standards were prepared solely for the purpose of evaluating instrument performance.
All standards received were marked with the date received and date opened. Silanized 
(deactivated) glass vials were utilized for all narcotics to prevent degradation.
Standard solutions were kept in the freezer at 0°C (temperatures are monitored)
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when not in use and were allowed to warm to room temperature before analyses. 
Dilutions were performed using Eppendorf™ pipettes and volumetric glassware. All 
glassware was rinsed with solvent before use. All vials were labeled with compound 
name, concentration, solvent, date of preparation, and initialed and stored in a freezer.
Instrument blanks were performed by analyzing positive and negative mode 
standards, supplied by Barringer Instruments. These standards contain verification 
compounds, with peaks at Ko values of 1.53. 1.21. and 1.00 cm2V '1s '1 for the positive 
mode and peaks at Ko values o f 1.45, 1.39, 1.31, 1.15, and 1.10 c n rV 'V  for the 
negative mode [39]. Analyzing an empty tray slide allowed the IONSCAN 400 baseline 
to be checked. A background o f the Teflon sample membrane (50 pm pore size) was 
performed before each analysis. The Teflon membrane was analyzed using standard 
conditions for the IONSCAN 400 until a satisfactory flat base line was achieved with 
only the reactant ion peak being present. Additional procedures included analyzing 
acetonitrile and methanol on separate Teflon membranes to ensure contamination-free 
solvents.
A five point calibration curve (concentrations ranging from 1 ng/pL to 25 ng/pL) 
was generated for cocaine hydrochloride in order to determine a concentration sufficient 
for quality control checks (Fig. 3). Quality control standards within the linear range o f 
the calibration curve (1 ng — 50 ng cocaine hydrochloride) were analyzed prior to the 
day's analyses and the signal obtained was compared to those obtained in previous days. 
Corrective actions were taken as necessary. A five point calibration curve 
(concentrations ranging from 1 ng/pL to 20 ng/pL) was also generated for TNT.
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A sample calibration curve is shown in Fig. 4. TNT standards were used for the quality 
control checks in the negative mode in the same manner described above.
Assessment and Maintenance o f Instrument Performance. Routine maintenance 
procedures for the IMS included cleaning of the inlet liner and condenser tube monthly 
with methanol. Silanized glass wool was placed inside the inlet liner to prevent the 
introduction of solid particles into the IMS drift tube. The dessicant was changed in the 
air purification tube when the indicator changed color. The sintered and dust filters on 
the back of the detector and pump modules were also cleaned regularly [37]. If 
unexplained problems were noted, changing the dessicant was the first corrective action 
pursued.
All information regarding instrument operation and service was recorded in the 
instrument log book. The log book was dedicated to the IONSCAN 400 and updated 
after each use. The log book was also used to note all service records and maintenance 
information.
Problems that have been encountered in using IMS include decrease in target 
analyte signal, presence o f  extraneous peaks, shift in Ko values, and absence of reactant 
ion peak. Possible causes for the signal decreases and extraneous peaks are dirty inlet, 
leaks, degradation o f sample, contamination o f the drift tube, and competition in reactant 
ion chemistry with another compound [40]. A shift in Ko values may indicate the 
presence of water in the system and/or spent dessicant in the air purification unit. An 
absence of the reactant ion peak may indicate a leak, contamination, or the glass wool 
being packed too tightly [40]. Corrective actions are taken appropriate to each situation 
and recorded in the instrument log book.
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Fig. 4. IMS calibration curve for 1 — 20 ng 2,4,6- trinitrotoluene (TNT) (Ko, 1.45 
c m W 1).




Experiments were performed to determine data variability within daily, day to 
day. month to month, and year to year time frames. Fig. 5 illustrates 25 ng/pL of 
cocaine hydrochloride analyzed in the morning (approximately 10 AM), afternoon 
(approximately I PM) and evening (approximately 5 PM) on four different days within 
one month. The instrument was left on during the day between each set of 
analyses. It was turned off at night. Samples were analyzed on different days using 
diluted cocaine standards from a certified solution o f cocaine hydrochloride. The one 
exception was sample D, which was made from solid cocaine hydrochloride of high 
purity. Fig. 5 illustrates that there can be significant variation during the day. Samples 
A. B. and C show higher instrument sensitivity at the end of the day. This variation is an 
exception and was noted during a period in which unexplained variations were observed. 
It is being brought out as an example why QC checks are important on a daily basis. It 
was concluded that the variation was due to the instrument rather than sample integrity 
especially since the sensitivity was increasing rather than decreasing. One possibility 
with the morning samples might be that the desorption temperature had not reached the 
set level. However, there is an instrument control which indicates the all settings have 
been reached after the warm-up period. Perhaps there was a malfunction; however, the 
exact cause was not found.
Figs. 6 and 7 show the month to month variations for the average amplitude and 
Ko values for 25 ng/pL cocaine hydrochloride run in 9 consecutive months. The data in
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Fig. 5. An illustration o f within day variations for four different days. Twenty-five ng 
o f cocaine hydrochloride were analyzed in the morning (approximately 10 AM), 
afternoon (approximately 1 PM), and evening (approximately 5 PM).
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Fig. 6. An illustration o f month to month variations for the average amplitude o f 25 ng/ 
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Fig. 7. An illustration o f month to month variations for the average Ko value for 25 
ng/pL cocaine hydrochloride.
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Fig. 6 represents the averages of triplicate analyses for the daily QC checks. The month 
to month variation is significant for the average amplitudes, which may range from 200 
du to 425 du. The Ko variations (Fig.7) are very small, with the Ko value ranging from 
1.155 to 1.157 cm2V 'ls '1. We have been using three significant figures for Ko which 
brings the average to 1.16 for every month.
Year to year variations are shown in Fig. 8. Calibration curves for 1995, 1996, 
1997, and 1998 are given for 1, 2, 5, 10, 25, and 50 ng of cocaine hydrochloride. Curves 
obtained in 1995 and 1997 show little difference. The 1998 calibration curve performed 
in 1998 also seems to correlates well with those from 1995 and 1997 except for the point 
from 50 ng o f cocaine hydrochloride. The calibration curve obtained in 1996 exhibits 
the highest amplitudes for all concentrations. It should be pointed out that different 
operators were involved. It is clear that calibration curves should be obtained often for 
specific compounds when semi-quantitative analyses are an objective.
Determination o f  Precision
Precision was determined using 25 ng/pL cocaine hydrochloride, 10 ng/pL of 
AEME and EME, and 0.5-1 mg of animal tissue. Each set of analyses comprised fifteen 
consecutive replicates with different samples of the same analytes. The time to complete 
the fifteen runs ranged from one half-hour to one hour. Fig. 9 exhibits the results for 
cocaine. The average amplitude for was 507 du with a standard deviation (SD) of ± 39 
and a relative standard deviation (RSD) of 7.7%. Fig 10. shows data for AEME with an 
average amplitude of 483 du, SD of ± 44, and RSD o f 9.0%. Data for EME is shown in 
Fig. 11. The average for 10 ng/pL of EME is 628 du, with a SD o f ± 46 and a RSD of 
7.3%. Fig. 12 illustrates data from fifteen analyses for A-43 brain tissue. The two ion
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Fig. 8. An illustration o f the year to year variations for 25 ng/jiL cocaine hydrochloride 
(Ko, 1.16 c m V ’s '1). The calibration curves are based on using 1- 50 ng o f cocaine 
hydrochloride.
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Fig. 9. Precision results for fifteen consecutive analyses of 25 ng/pL cocaine 
hydrochloride (Ko, 1,16 c m V s '1). The average amplitude is 507 du, with a SD of ±39 
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Fig. 10. Precision results for fifteen consecutive analyses o f 10 ng/pL AEME (Ko, 1.50 
cirT V 's'1). The average amplitude is 483 du, with a SD o f ±44, and RSD o f 9.0%.
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Fig. 11. Precision results for fifteen consecutive analyses of 10 ng/fiL EME (Ko, 1.48 
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Fig. 12. Precision results for fifteen consecutive analyses of 0.5-1 mg A43 brain tissue. 
The peak at Ko 1.65 cm2V 'ls‘l has an average amplitude o f 258 du, with a SD of ±22, 
and RSD of 9.0%. The peak at Ko 1.57 cm 'V 'V  has an average amplitude of 168 du, 
with a SD of ±28 and a RSD o f 17%.
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peaks inherent to the tissues as described in Chapter IV were measured. The peak at Ko 
1.65 c rrrV 'V  has an average o f 258 du, with a SD o f ± 22 and a RSD of 9.0%. The 
other peak at Ko 1.57 cm2V*'s*1 has an average amplitude o f 168 du, a SD of ± 28 and a 
RSD of 17%. The statistical data for Ko values for cocaine, AEME. EME, and animal 
tissues are given in Table 5.
Table 5
Statistical data for the Ko values of cocaine, AEME, EME, and A-43 brain tissue.
Analyte Average Ko value 
(c n rV ’s '1)
Relative Standard Deviation3
Cocaine hydrochloride 1.17 ±0.00 0.01%
AEME 1.51 ±0.00 0.02%
EME 1.49 ±0.00 0.05%
A-43 Brain tissue 1.66 ±0.00 0.02%
Peak 1
A-43 Brain tissue 1.53 ±0.00 0.01%
Peak 2
“Calculated using four significant figures for Ko values rather than three 
shown in the table.
Discussion and Conclusions
QC procedures were established to ensure that IMS data generated is accurate 
and precise enough for their intended use, i.e.. screening vs. semi-quantitative analysis. 
Cocaine standards supplied, by a manufacturer, were used to determine whether the IMS 
procedures were under statistical control. The results were excellent indicators of 
instrument variability. Diluted solutions o f the primary standards were used to ensure 
that calibration stays in control and that detection limits are satisfactory. Peak 
amplitudes and Ko values were established for QC check solutions that must be met each 
day before proceeding further. For example, if the peak amplitude o f the QC solution
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was significantly lower than the amplitudes observed form the calibration curve o f the 
same solution, or there was a significant shift in Ko values o f  the solution, corrective 
procedures were implemented. Any deviation from the criteria requires assessment of 
the problem and corrective action. The procedure was found helpful in maintaining 
data quality, and in providing an early indication of potential problems.
It is concluded that cocaine is a useful standard for IMS QC in the positive 
mode. Cocaine hydrochloride, (as well as the freebase) when analyzed by IMS, 
decomposes with the appearance o f an ion peak corresponding to the formation of 
AEME. The extent o f decomposition depends on temperature, heating time, and nature 
of the IMS desorption surface. Greater than expected decomposition of cocaine 
standard has served as an important indicator that instrument checks need to be 
performed before proceeding further.
Precision of IMS analyses was determined for cocaine hydrochloride, AEME, 
EME. and 0.5-1 mg o f brain tissue from rabbits. Based on the results, it was concluded 
that the results justify development of semi-quantitative methods based on IMS for 
cocaine. AEME. and EME with appropriate calibration curves.
The precision data obtained from the IMS of brain tissue were interesting. It is 
concluded that the reproducibility o f the tissue background will facilitate analysis of 
drugs and metabolites in animal tissues.
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CHAPTER IV
ION MOBILITY SPECTROMETRY OF ANIMAL TISSUES 
Introduction
Today's clinical laboratory has the capability of analyzing many substances 
including proteins, trace metals, tumor markers, and different drugs in tissues harvested 
from diseased areas of the body. Useful methods also include immunoassays, titration 
assays, colorimetric assays, centrifugation analysis, chromatographic methods, and 
immunocytochemical assays just to a mention several. Such analyses have provided 
information concerning malignant organs as well as organs damaged by chronic drug 
use or autoimmune reactions.
IMS may be an attractive alternative and/or a useful adjunct in the analysis of 
tissues and other substances o f biological origin. IMS was used in the present research 
to detect the presence of cocaine and other physiologically active substances in tissues 
harvested from New Zealand white rabbits. The specific details o f  these studies are 
addressed in chapters V and VI. The present chapter describes the IMS o f control 
tissues under different conditions as baseline information for studies o f tissues from 
animals exposed to drugs.
Control tissues from non-pregnant rabbits, pregnant rabbits, and their fetuses 
were analyzed for ion peaks innate to the animal tissues themselves and to establish 
whether such peaks coincided with peaks from drugs or metabolites. This served as a 
basis for establishing windows which could be used for compounds of interest.
The tissues examined from the maternal and nonpregnant adult rabbits were 
brain, lung, kidney, renal artery, atria, ovary, and liver. The fetal and cotyledon, heart,
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spectra might be due to these compounds. Peaks appearing in positive-mode mobility 
spectra kidney, lung, and liver were also analyzed. Assay reproducibility between 
animals, and assay variations within organs were determined. Optimizations of IMS 
parameters, desorption temperature, analysis time, and sample amount for tissue 
analyses were also defined.
Results
IMS Signatures o f  Animal Tissues: Positive and Negative Mode Fingerprints
The mobility spectra obtained from analyzing animal tissues in the positive 
mode generally exhibited at least four peaks with Ko values 1.65. 1.52, 1.38, and 1.31 
c m V s '1. An example using C3 brain tissue is shown in Fig. 13. Other examples are 
given in Appendix A. The ion peaks are not necessarily inherent to the tissues since the 
animals and harvested tissues were exposed to various chemicals including euthanizing 
agent (main ingredient - pentabarbitol, minor ingredient - benzyl alcohol), anesthetics 
(Ketaset and Rompun) and heparin (Fig. 14). The Ko values o f  tissues harvested from 
animal C3, and compounds used with animals and/or tissues, are given in Tables 6 and 
7. respectively.
The ion peaks of highest amplitude shown in Table 7 arise from the anesthetics 
Rompun and Ketaset at Ko values 1.38 cnT V V 1 and 1.37 cm2V 'ls '1. respectively. The 
next highest is from heparin at 1.31 c n rV 'V . The concentrations of all o f the 
compounds are much higher relative to the sensitivity that IMS is generally capable of. 
High amplitudes such as observed when analyzing Rompun and Ketaset alone may also 
reflect saturation of the spectrometer. Lower concentrations were also run and are
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Fig. 13. The positive mode IMS mobility spectrum of brain tissue from animal C3 
(control animal given vehicle saline in an acute study). Ko values 1.65 and 1.52 
cirrV ’s '1 are native to the tissue. A Ko value 1.38 cm2V '‘s '1 is attributed to the 
anesthetic given during surgery.





























































IMS peaks of tissues obtained from animal C3. This animal received saline in an acute 
study
Organ Peak Number Ko
( c n r V 'V 1)
Amplitude
(du)
Renal Artery 1 1.38 269
2 1.31 60




Adrenal 1 1.65 46
2 1.51 503
J 1.31 28
Liver I 1.65 53
2 1.38 90
Kidney 1 1.65 95
2 1.38 577
Atria 1 1.38 251
2 1.31 734
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Table 7
The IMS Ko values and amplitudes of 1 pL o f compound solutions used routinely with 






( c m V s '1)
Amplitude
(du)
Rompun 100 1 1.38 884
2 0.91 49
Ketaset 100 1 1.47 42
2 1.37 978
J 1.03 63
Euthanasia 3.24b 1 1.44 219
2 1.38 184
Benzyl Alcohol 100% 1 1.40 256
2 1.45 86
Heparin 1 unit/pLa 1 1.31 663
a Each mL o f heparin contains 1000 USP units. USP is a measurement of 
anticoaeulant activity.
^Calculated as pentabarbitol, the major component.
described in Chapter V. However, the results with high concentrations give a first 
indication that any peaks with same Ko values appearing in tissue sample mobility of 
animal tissues (Table 6) that coincide with peaks from compounds listed in Table 4. 
have Ko values of 1.38 c m V s '1 and 1.31 c m V 's '1. These could arise from the 
anesthetics, euthanizing agent and heparin.
The anesthetics, Rompun and Ketaset, though different compounds (xylazine 
and ketamine, respectively) have Ko values which overlap and are not distinguishable 
using IMS. The relatively low molecular weights of Rompun and Ketaset (220.3 and 
237.7, respectively), low melting points (140 — 142 °C and 92-93 °C, respectively), 
[41.42] and the presence of a secondary amine function (high proton affinity) would 
lead to the expectation of strong IMS peaks as was found (Table 7).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
54
A weak peak with K<, 1.38 cm2V‘ls '1 was found in the mobility spectra o f brain 
tissue from an animal that received euthanasia but no anesthesia (Fig. 15A). This ion 
peak may be inherent to the brain tissue or may arise from the euthanasia. A weak peak 
was found for a relatively high amount of euthanasia (Table 7). There were two 
animals that died spontaneously and received anesthesia, but not euthanasia. Tissues 
from these animals exhibit relatively high peaks at Ko 1.38 cm2V*1s"1. Though these 
peaks can not be assigned unequivocally, the strong IMS response to Ketaset and 
Rompun coupled with the strong peaks found in the tissues o f animals treated with 
anesthesia. leads one to conclude that the peak at 1.38 cm2V '1s '1 is largely due to 
anesthesia, with the euthanizing agent playing a minor role. Further evidence was 
obtained when Rompun was added in vitro to brain tissue. The mobility spectrum (Fig.
15B) appeared identical to that o f brain tissue from an animal receiving anesthetic (Fig. 
13). This also means that the mobility spectrum region at or in the vicinity o f Ko 1.38 
cm2V"1s '1 cannot be used for making conclusions as to the presence of a particular drug 
or metabolite for animals receiving Rompun and Ketaset.
Assignment o f the peak at Ko 1.31 c n rV 'V  in animal tissues also could not be 
done unequivocally although heparin did exhibit the peak (Table 6). Heparin was 
injected into the animal systemically (intravenously or intra-arterially) and was used as 
an anticoagulant when obtaining blood samples. Heparin is a heterogeneous mixture o f  
variable sulfated polysaccharide chains composed of repeating units o f D-glucosamine 
and either L-iduronic or D-glucuronic acids. The molecular weight ranges from 6.000 
-  30,000 Da [43]. The IMS signal is most likely due to thermal decomposition which 
might be avoided at lower IMS desorption temperatures, but was not investigated.















• s  3 0 0
J? 20 0
1 0 0
R e a c t a n t  Ion P eak
4 166 8 10 12 14 18 20
Drift  T i m e  (ms )
C 4  B r a i n  T i s s u e  a n d  R o m p u n B
R e a c t a n t  Ion P e a k
-> 4 6 8 1610 1 2 14 18 20
D ri ft  T i m e  (m s)
Fig. 15A and 15B. The positive mode IMS mobility spectra o f brain tissue from animal 
C4. (A) Represents brain tissue that was not exposed to anesthetic. (B) Represents 1 
pg/pL of Rompun added to brain tissue in vitro.
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The negative IMS mode (negative ions) was examined also as a means o f 
characterizing the tissues. Fig. 16 illustrates an example of results from brain tissue.
The Ko values and amplitudes for C3 animal tissue analyzed in the negative mode are 
given in Table 8.
The euthanizing agent and anesthetics were also analyzed in the negative mode. 
However, there did not seem to be any direct correlation between peaks attributed to 
these compounds and peaks present in the animal tissue spectra.
Optimization o f  Sampling Time and Desorption Temperature
Sampling times (during thermal desorption) were varied, from 5 to 20 seconds, 
for brain tissue and anesthetics as representative materials for optimization of sensitivity 
(Ko 1.38 c m V s '1). Sampling times of 8 and 5 seconds for brain tissue and anesthetic, 
respectively, in a mixture of brain tissue and anesthetic, gave the highest peak 
amplitude (Fig. 17). No new peaks were observed with the longer times.
The desorber temperatures were varied from 100°C to 350°C to examine effects 
on peak amplitude for brain tissue and anesthetic. The highest amplitudes for the 
analysis o f brain tissue and anesthetic were found at 250°C and 200°C, respectively.
(Fig. 18) A sampling time of 8 seconds and desorption temperature of 285°C were 
chosen for the remaining experiments in the study as reasonable conditions to detect 
major changes to the IMS characteristics o f both animal tissue and anesthetic. This is 
not meant to imply that these are the best choices for every purpose. For example, a 
much lower desorption temperature may eliminate tissue background peaks and yet 
allow specific analytes to be readily analyzed. Investigators need to optimize sampling 
time and desorption temperature consistent with objectives o f each specific study.
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Fig. 16. The negative mode IMS mobility spectrum of brain tissue from animal C3.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
58
Table 8
IMS peaks from C3 animal tissue in the negative mode
Organ Peak Number Ko ( c n r W 1) Amplitude (du)
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S A n e s th e t i c  595.9 438.1 488.9 363.4 140.3
Sampling Time (s)
250 ^  Peak 1
q Peak 2
5 8 10 15 20
Peak 1 " 150.1 204 .3  179.1 193.1 88.3
□  Peak 2 59.9  146.2 101.1 ‘ 132.8 125.5
Sam pling  Tim e (s)
Fig. 17 A and 17B. Optimization o f sampling time for the IMS analysis o f C3 brain 
tissue with anesthetic. (A) The optimal sampling time for anesthetic is 5 seconds. (B) 
The optimal sampling time for compounds innate to brain tissue is 8 seconds.
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Fig. 18A and 18B. Optimization o f desorber temperature for the IMS analysis o f C3 
brain tissue with anesthetic. (A) The optimal desorption temperature for anesthetic is 
200°C. (B) The optimal desorption temperature for compounds innate to brain tissue is
250°C.
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IMS o f  Plasma
Plasma, urine, and amniotic fluids were collected from rabbits and analyzed 
using IMS. All animals received anesthetic, heparin, and in some cases EME. Plasma 
samples were taken at times ranging from 0 minutes to 30 minutes after a drug or sterile 
water was administered.
Fig. 19 illustrates a plasma sample from animal C l, collected directly after the 
injection of sterile water. In this mobility spectrum, there is a peak at Ko 1.38 c m V s '1. 
which corresponds to the mobility constant of Rompun. Fig. 20 shows a peak of 1.49 
c rrrV 's '1. which corresponds to EME. It was interesting that a peak for Rompun was 
absent. This animal (A 15) was pregnant and received an intramuscular injection of 2 
mg/kg EME. The plasma sample was collected 5 minutes after EME was injected, 
received an intramuscular injection of 2 mg/kg EME. The plasma sample was collected 
5 minutes after EME was injected.
The time of collection o f the plasma affects the amplitude o f the IMS drug peak. 
Fig. 21 illustrates the collection of plasma from animal C3 at times ranging from 0 to 20 
minutes. This chart shows that anesthesia is detectable immediately after the injection 
of the drug. The peak amplitude of anesthesia decreases with increasing sampling time. 
This trend was subjected to regression analysis, which indicated that it was significant 
at P <0.01.
It was found that both anesthetic and EME could be detected in a urine sample 
collected for 24 hours from animal A3 after injection with EME. Fig. 22 shows that 
there are distinct peaks at 1.38 and 1.49 cm2V 'ls '1, assigned to anesthesia and EME, 
respectively.
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Fig. 19. IMS mobility spectrum of plasma from animal Cl collected directly after 
injection of sterile water. The peak at K<, 1.38 c m 'V 's '1 indicates the presence o f 
anesthetic.
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Fig. 20. IMS mobility spectrum of plasma from animal A15 which received an 
intramuscular injection o f 2 mg/kg EME. The plasma sample was collected 5 minutes 
after EME was administered. The peak at Ko 1 -49 cm2V"'s‘1 indicates the presence o f
EME.
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Fig. 21. Amplitudes o f the ion peak corresponding to anesthetic (Ko, 1.38 cm2V '1 s '1) 
from the IMS analysis o f plasma (animal C3) collected at different time intervals.
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Amniotic fluid was collected from an animal in a chronic study, with cocaine 
being administered via an Alzet pump for 14 days. In the mobility spectrum o f this 
fluid, there is a peak at Ko 1.38 c m V s '1. which corresponds to the mobility constant of 
Rompun (Fig. 23).
Based on these preliminary results, it appears that IMS may be very useful in 
analyzing drugs and metabolite directly in biological fluids. Useful information may be 
obtainable relative to metabolic rates by varying sample collection time. There appears 
to be great potential in the use o f IMS to analyze biological fluids directly. Additional 
work is necessary including gathering data with control animals to fully appreciate the 
possibilities.
Acute vs. Chronic Studies
In acute studies, the animals were sacrificed approximately 24 hours after 
surgery, and in chronic studies after 10 days. In some cases, it appears that the presence 
of any drug given in the chronic study has been completely metabolized and does not 
appear in the mobility spectra. The analysis o f tissue from an acute study generally 
exhibits medium or large amounts of anesthetic. Additional information and specific 
examples are given at the end o f this chapter.
Animal to Animal Variations
Animal to animal differences in tissue results may depend on animal gender and 
age. There appears to be no overall differences between tissue from a non-pregnant 
animals and tissue from a pregnant one. Fetal tissue and adult tissue differ in the 
relative amplitudes o f the peaks seen in their mobility spectra. Fetal tissue also exhibits 
several peaks that are lower in ion mass and are not present in adult tissue.
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Fig. 22. IMS mobility spectrum of urine from animal A3 collected over 24 hours after 
injection with EME. The peaks at Ko, 1.49 c m V 1 s '1 and Ko, 1.40 cm2V '! s '1) indicate 
the presence of EME and anesthetic, respectively.
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Fig. 23. IMS mobility spectrum o f amniotic fluid from animal A28. The peak at Ko, 
1.38 c m V s ' 1 indicates the presence of anesthetic.
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Evidence suggests that anesthetic given to a pregnant rabbit appears in the tissue 
of her fetuses (Fig. 24). However, no control fetal tissues were available from pregnant 
rabbits not receiving anesthetics. Brain tissue was chosen as a representative organ for 
most o f the animal tissues examined. A comparison (Fig. 25) o f tissues from different 
animals shows that there are two peaks native to brain tissue in each case (Ko 1.65 and 
1.51cm2V'1s '1). Anesthetic peaks (Ko 1-38 cm2V'ls l) appeared with all o f the samples 
except two (A43 and A44). A peak at Ko 1-31 c n rV 'V  was present at low intensities 
in all o f the tissues excluding C l and A44. A new peak (Ko 1.16 cn rV 's* 1) was 
observed in animal tissues A39 and A44.
Discussion
The specific aim o f this study was to analyze rabbit brain, lung, kidney, renal 
artery, atria, ovary, and liver harvested from animals and to determine whether the 
potential exists to characterize them using IMS. Another aim was to determine whether 
a sufficient number of windows were open in the IMS mobility spectra to allow drugs 
and/or their metabolites to be directly identified in the tissues without the need of 
performing extractions or employing special recovery procedures.
Rabbits were utilized since tissues were available from an independent study in 
the Department of Biological Science. Old Dominion University, (Principal 
Investigator: Professor Barbara Y. Hargrave) on the effect o f illicit drugs on the 
cardiovascular and hormonal system o f pregnant New Zealand white rabbits.
The IMS analysis o f tissues from a variety o f organs under the condition 
chosen, demonstrated the feasibility o f characterizing animal tissues. Analyses were 
performed both in the positive and negative modes.
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Fig. 24. The positive mode IMS mobility spectrum o f fetal lung tissue from animal 
A40 (a control animal given vehicle saline in a chronic study). K<, value 1.38 c n rV 'V  
is attributed to anesthetic, given to the mother during surgery, which has passed through 
the cotyledon to the fetus.




1.65 1.51 1.38 1.31 1.16
Animal num ber Amplitude
Cl 251.9 136.7 308.2
C3 204.3 146.2 438.1 64.8
C4 339.8 174.8 56.8 20.3
A27 265.7 182.6 390.2 39.1
A39 201.1 129.9 27.7 28.2 63
A40 354.1 153.5 30.8 29.8
A43 137.4 127.5 26.9
A44 191.2 94 65
Fig. 25. A comparative analysis of the IMS Ko values and amplitudes of the brain tissue 
analyzed for the animals included in the study.










It was interesting to find that the positive ion mobility spectra of the tissues had 
two ion peaks that were common to most of the tissues analyzed (Ko 1.65 and 1.52 
c n rV ’s '1). As shown in Table 6, all of the tissues (nine organs) except for the ones 
from renal artery and atria, exhibited the 1.65 c m V s '1 peak. The liver and kidney 
tissue mobility spectrum showed the 1.65 cm2V 'ls '1 peak, but not the one at 1.51 cm2V' 
‘s'1. For tissues exhibiting both peaks, the one at 1.65 cm:V 'ls '‘ was more intense than 
the one at Ko 1.51 cm2V"‘s '1 except for adrenal tissue. In the latter case, the Ko 1.51 
cm2V '1s’1 peak intensity was one of the highest found among all organ tissues. The 
peaks with highest amplitudes among all the tissues, irrespective of Ko value, were atria. 
734 du (Ko, 1.31 cm V s ' 1); kidney 577 du (Ko, 1.38 c m V ’s '1); lung 517 du (Ko, 1.38 
c n rV 'V ); and adrenal, 503 du (Ko, 1.51 cm2V '1s '1).
Two other peaks appeared in the positive ion mobility spectrum of most o f  the 
tissues (Ko 1.38 and 1.31 cm2V '1s '1). As indicated in the Results section, it is very 
likely that they are from the anesthetic agents and heparin, respectively. It was 
interesting to note that the amplitude at Ko 1.38 cm2V '‘s '1 varies from 0 to 578 du 
among the nine different tissues. As mentioned earlier this peak is most likely due to 
the anesthesia (Rompun or Ketaset). Sufficient information is not available to 
determine the physiological significance, however, it does identify a potential area for 
additional research, and how IMS may be useful in clinical chemistry research.
The peak with Ko 1.31 c n rV 's '1 may be due to heparin. However, with most o f 
the tissues the intensity was very low. Tissues from atria and ventricle exhibited higher 
intensities, 734 du and 259 du, respectively. It is not surprising that heparin would
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accumulate in heart tissues, but assignments of the Ko 1.31 cm2V"‘s '1 are not 
unequivocal. No control was available since all animals received heparin.
The distribution o f anesthetic and heparin among tissues from animals receiving 
these compounds may be useful indicators for physiological purposes and may help to 
differentiate the various tissues. However, we also examined the tissue patterns 
between tissues in which only peaks with Ko 1.65 c n r V 's '1 and Ko 1.51 c n r V 's '1 were 
present (Fig. 26).
The distinguishing features o f negative ion mobility spectra are the number of 
low intensity peaks. This implies that the tissues decompose under thermal desorption 
to give a number o f products eventually leading to negative ions as a result of the IMS 
chemistry. It is also interesting to note that the reactant ion peak is absent in Fig. 16. 
This indicates that the reaction ion chemistry was not completed. It also implies that 
(H;>0)n02' is not specific enough for tissue samples. Reactant ions with higher electron 
affinity may give more useful mobility spectra.
The major negative ion peak among all tissue samples has a Ko value of 1.83 
c m V ’s '1. However, this is not true o f every sample. In the case of renal artery and 
kidney tissues, the ion peak with Ko 2.19 cm2V'ls '1 is the most intense. (These two 
peaks appear in every sample.) The second most intense peak in brain, liver, lung, and 
ovary tissues has a Ko value o f 1.50 c m V s '1.
The Ko values in the negative mode for tissue correspond to negative ions of 
lower mass than the positive ions found using the positive mode. The negative mode is 
usually preferred for analytes with high electron affinity. Drugs such as cocaine and 
heroin (and their metabolites) have high proton affinity and are normally analyzed in





























Fig. 26. A comparison o f IMS values (1.65 and 1.51 cm2V '1s '1) and amplitudes for 
organs from C3 animal tissue.
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the positive mode. Since the present work focuses on cocaine, heroin and related 
compounds, research on optimizing the negative mode conditions and choice o f reactant 
ion for clinical chemistry applications were not pursued. Some experiments, however, 
were performed in the negative mode and are described in Chapter V.
The origin of the ion peaks innate to animal tissues (e.g., Ko 1.65 and 1.51 
cm2V 'ls '1) in the positive mode), is not clear. These could be compounds within the 
tissue (e.g.. hormones) or they could be compounds formed from tissue decomposition 
during thermal desorption in the IMS sample chamber. The source in the latter case 
might be proteins. The ions contained in mobility spectra can be identified using IMS- 
MS, however, this equipment was not available. Such research will undoubtedly be 
accomplished as interest in IMS of animal (and human tissues) grows.
Much IMS data can be gathered within a relatively short period o f time. There 
are many instrumental parameters that can be varied including the major ones of 
sampling time and desorption temperature. A choice of low desorption temperature 
may eliminate ion peaks due to the tissue and open up the entire mobility spectrum 
window for target analytes. In our studies, much lower temperatures could have been 
used to analyze anesthetics in animal tissues. There are many choices to be made in 
terms of selecting tissues from a single organ or many organs. One also has a choice of 
targeting negative or positive ions. The present work utilized air as a source o f reactant 
ions in the negative mode, and nicotinamide as a source of reactant ions in the positive 
mode. The choices of ion mode and reactant ion chemistry allow much flexibility in 
targeting analytes of interest. As more experience is gained with IMS o f tissues, use of 
pattern recognition techniques should be very helpful in helping to develop specific
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IMS methods. It is also clear that IMS of tissues is not limited to clinical chemistry 
applications. Use in pathology and forensic applications are very promising as well. 
Applications of IMS Animal Tissue Research
As mentioned above, the IMS animal tissue research was done in collaboration, 
between the Department o f Biological Sciences and the Department o f Chemistry and 
Biochemistry with project leaders being Professors Hargrave and Poziomek, 
respectively. The students from the Biological Sciences Department were Barbara B. 
Guinn and Andrea Chambliss. Details of the biological part o f the research can be 
found in their Master o f Science theses [35, 44]. They represent early examples o f how 
IMS of animal tissues can be applied in biological sciences research.
Effect o f  Cocaine on Plasma Renin Activity in Male Rabbits: Cocaine Detection in Male 
Plasma and Tissue Using Ion Mobility Spectrometry (IMS)
Animal tissues were harvested from male New Zealand White (NZW) rabbits in 
studies where each rabbit was given an intra-arterial injection o f  2 mg/kg cocaine 
hydrochloride. Tissues and plasma prepared in the manner described in the 
Experimental section. Results o f these experiments indicated that EME was 
consistently detected in the mobility spectra o f all plasma samples five minutes after the 
injection of cocaine. EME was also detected by IMS in the tissues from lungs, liver, 
kidneys, and testicles harvested from these animals. GC/MS was use to validate the 
IMS assignment o f EME in plasma samples.
IMS calibration curves o f tissues and plasma were spiked with cocaine, EME, 
and BE were used to determine whether IMS results could quantify the amount of 
cocaine or EME present in plasma and tissue. It was found that BE could not be
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identified in the presence (or suspected presence) of cocaine because o f the similarity of 
Ko values between the compounds. The ion peak from BE is hidden under the cocaine 
peak because the IMS sensitivity to BE is less than that o f cocaine.
A study varying the optimal sample size of animal tissues for IMS was also 
performed. It was determined that varying the sample size did not significantly change 
the mean IMS amplitudes o f  tissue samples. These results led to a standard sample size 
of 0.5-1 mg animal tissue for in vitro experiments in which calibration curves for 
mixtures of target analytes and tissue were being generated and for qualitative in vivo 
studies. Calibration curves were obtained for tissues from atria, ventricles, lungs, 
kidneys, liver, and testicles, each spiked with cocaine hydrochloride or EME.
It was also found that EME can be detected in most tissues from animals treated 
with cocaine hydrochloride. Highest amounts were found in kidneys and lungs. Very 
little was found in heart tissues. EME was consistently detected in all plasma samples 
five minutes after the injection o f cocaine hydrochloride. This research represents the 
first example of using IMS o f animal tissues from in vivo studies.
Effect o f  Cocaine on Renin Angiotensin System: Cocaine Detection in Adult and Fetal 
Tissue and Adult Plasma Using Ion Mobility Spectrometry (IMS)
In a related study, IMS was used to detect cocaine hydrochloride and/or its 
metabolite, EME, in both maternal and fetal tissues and maternal plasma o f pregnant 
rabbits. EME was consistently detected in all plasma samples five minutes after intra- 
arterial injection of cocaine hydrochloride (2 mg/kg). EME was also detected in all 
maternal and fetal tissue samples analyzed. Cocaine and EME were detected in the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
76
tissues o f the two young fetuses analyzed. Control tissues were also spiked in these 
studies and GC/MS was used to confirm the IMS results.
More specifically, cocaine was detected in 57% of maternal kidneys, while 
lesser amounts were found in the atria and ventricle, 17% and 40%, respectively, from 
seven pregnant rabbits. EME was detected in ail o f the maternal liver, kidneys, and 
ventricle tissues, while 67% o f the atria and 80% of the lung tissues contained EME.
For fetal tissues, cocaine was detected in 20% of the livers, 40% o f the kidneys. 20% of 
the lungs. 20% of the hearts, and 40% of the cotyledons. EME was detected in all fetal 
tissue samples. BE was not detected in any o f the tissue or plasma samples.
Effect o f  Illicit Drugs on the Cardiovascular and Hormonal Responses in Pregnant 
Rabbits
Another study focused on giving injections o f EME (2 mg/kg) and heroin (2 pg) 
instead of cocaine to pregnant rabbits. EME was studied since the biological and 
pharmacological activity o f this compound has not been proven and recent data 
interpretations are still controversial. The IMS results should indicate the presence of 
EME in all maternal and fetal tissue samples. Strong EME IMS signals were found in 
maternal adrenal glands, kidney, brain, and heart. Lesser, but detectable amounts were 
found in all fetal tissues. However, generation o f quantitative data will require 
additional method development.
IMS analysis o f tissues harvested from animals exposed to heroin, showed no 
ion peaks at the mobility constants expected for heroin (Ko 1.04 and 1.14 cm2V 'ls‘1). 
Also, no ion peaks for heroin were observed in the mobility spectra o f control tissues 
spiked with heroin at concentrations below 200 ng.
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Additional studies were conducted where morphine was added to control tissues. 
Results indicated that at least 8000 ng o f morphine had to be added to tissue before a 
peak corresponding to morphine was observed. Confirmatory tests with GC/MS, 
however, indicated the presence o f heroin in the animal tissues. More detailed 
discussion of the heroin and morphine retardation effects is given in Chapter VI.
All of the studies described above point out the feasibility of developing IMS as 
a useful adjunct to physiological studies, but additional research needs to be conducted 
to refine the methodology for specific applications, especially if semi-quantitative 
information is required.
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CHAPTER V
ORIGIN OF ION PEAKS IN THE MOBILITY SPECTRA OF ANIMAL
TISSUES
Introduction
It was illustrated in the previous chapter that IMS has much potential in the 
analysis of drugs and metabolites in animal tissues. This also applies to the 
characterization o f the animal tissues. It was discovered that the IMS of tissues 
harvested from animals can reveal the compounds/drugs that the animals were exposed 
to. Ion peaks in the plasmagrams o f tissues from various organs were easily assigned to 
the anesthesia (Rompun and Ketaset) used with the animals.
It was also found that the tissues themselves had characteristic ion peaks which 
varied in amplitude between different organ tissues from the same animal. On the other 
hand, the ion peaks for a specific tissue (brain from rabbits, as an example) had 
amplitudes that were reasonably consistent between a number of animals. It is not 
known whether the ion peaks found with animal tissues also appear in tissues from 
different animal species.
The origin of the two characteristic ion peaks (Ko 1.65 and 1.51 cm2V"1s '1) is o f 
interest. The compound(s) could be a relatively non-volatile tissue component or a 
thermal decomposition product from heating the tissue samples in the IMS desorber 
unit.
The purpose o f this chapter is to extend the tissue research described in the 
previous chapter by examining relevant chemistry o f animal tissue using IMS. The 
specific aim is to learn more about the origin of the four ion peaks (Ko 1.65, 1.51, 1.38,
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and 1.31 c n rV 'V ) . The overall strategy includes learning more about the properties of 
Rompun and Ketaset, examining the potential o f quantifying the anesthetics contained 
in tissues, extracting animal tissues with solvents of different polarities in attempting to 
isolate sources of IMS peaks, reacting animal tissues with alkylating agents to examine 
effects on the IMS mobility spectra, and screening vegetable proteins, synthesized 
proteins, various amino acids, and naturally occurring complex materials 
for comparison to the IMS mobility spectra of animal tissues. Brief descriptions (not 
covered earlier) of the chemicals used follow.
Anesthesia Agents
Rompun and Ketaset were used as anesthesia agents with the animals from 
which tissues were harvested. Both compounds contain nitrogen moieties (Fig. 27) 
which undoubtedly provide sufficient proton affinity to give high detection sensitivity 
in the IMS positive mode.
Xylazine, the active ingredient o f Rompun, is a non-narcotic compound that acts 
as a sedative and analgesic as well as a muscle relaxant. It is generally used in 
veterinary medicine. Rompun's sedative and analgesic activity is related to central 
nervous system depression, while its muscle relaxant effect is based on inhibition o f the 
intraneural transmission of impulses in the central nervous system [41].
Ketamine, the active ingredient o f Ketaset, is a rapid-acting nonnarcotic, 
nonbarbiturate, dissociative anesthetic used mainly in small animals, but can be used in 
humans. It is also classified as a psychedelic drug and is often abused with 
phencyclidine (PCP) [45]. Ketaset is characterized by profound analgesia, mild cardiac








C l  CH-,  C H ,  S   CH,  CH,
2-Choroethyl ethyl sulfide
Fig. 27. Structures of xylazine (major compound in Rompun), ketamine (major 
component in Ketaset), and 2-chloroethyl ethyl sulfide, an alkylating agent.
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stimulation and respiratory depression, but maintains protective reflexes such as 
coughing and swallowing [42]. Toxic doses may cause severe muscle rigidity, an 
increase in blood pressure, and seizure activity. This drug is detoxified by the liver and 
excreted by the kidneys. The mechanism of action is thought to alter the interactions o f 
dopamine, serotonin, and norepinephrine with their receptors. Ketamine also binds to 
the sigma opiate receptor in the hippocampus of the limbic system [46].
Alky lating Agents
Two alkylating agents were used, 2-chloroethyl ethyl sulfide (Fig. 27) and 
methyl iodide. 2-Chloroethyl ethyl sulfide is commercially available (Aldrich) and is 
commonly used as a simulant for bis (2-chloroethyl) sulphide, a general cell poison that 
has been used as a chemical warfare agent (mustard). Mustard can severely damage 
any tissue, but its effects are readily seen on the eyes and skin. Inhalation o f  its vapors 
causes major corrosive effects, producing long-lasting lesions, bronchitis, 
bronchopneumonia, and eventually fatal lung edema [47]. We used 2-chloroethyl ethyl 
sulfide was used in in vitro studies with animal tissues.
Methyl iodide is another well-known alkylating agent used in our studies with 
animal tissues. It is a neurotoxin and narcotic that may produce severe pulmonary, skin 
and eye irritation. It also depresses the central nervous system and may cause 
convulsions, paralysis, hypotension, and coma.
Vegetable and Synthesized Proteins
The vegetable protein (soy isolate) (Protein 94) used contains 94% protein and is 
manufactured by Sundown®. The amino acid profile is given in Table 9. The vegetable 
protein also contains 5% calcium, 15% phosphorus, 6% magnesium, and 15% sodium.
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Table 9
Amino acid profile for Protein 94
Amino acid % Amino acid %
Isoleucine 3.7 Histidine 2.0
Leucine 6.4 Arginine 5.2
Lysine 5.1 Aspartic acid 9.5
Methionine 1.1 Serine 4.1
Cysteine 1.1 Glutamic acid 16.0
Phenylalanine 4.2 Proline 4.3
Threonine 2.9 Glycine 2.8
T ry ptophan 1.0 Alanine 2.8
Valine 3.8 Tyrosine 3.2
Slim Fast® (chocolate), purchased from a retail store, contains vitamins A, C, D, E, B6 
and Bi2 - It also contains a variety o f materials such as calcium, iron, thiamin, 
riboflavin, niacin, folate, biotin, panthenic acid, phosphorus, iodine, magnesium, zinc, 
and copper. The protein content is 5 g/28 g and is a soy protein isolate. The glycine 
peptides, purchased from Sigma, are listed in Table 10.
Amino Acids
Amino acids represent the most fundamental building blocks of protein. It was 
important to check whether any o f these materials or their thermal decomposition 
products were the source o f  the ion peaks found in IMS. A variety o f amino acids were 
selected (Fig. 28).
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Table 10








Glvcine 75.07 Room temp. G7126 99% TLC
Diglycine 132.1 Room temp. G3028 pKa 8.2 at 25°C
Triglycine 189.2 Room temp. G1377
Tetraglycine 246.2 0°C G3882
Pentaglycine 303.3 0°C G5755
Hexaglycine 360.3 0°C G5630 H2O content 0.5 
mol/mol
Polyglycine 4.600(vis)a >0°C P8790 DP(vis) 80a
Polyglycine
a-T~i i
5,200(vis)a >0°C P3548 DP(vis) 91a
aThe glycine peptides are a mixture o f  polymer chains differing in the degree of 
polymerization (DP). Both the molecular weight and DP are characterized using 
solution viscosity.
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Fig. 28. Structures o f amino acids analyzed using IMS.




Rompun and Ketaset were examined by IMS in both the positive and negative 
modes to assist in establishing a background control for animal tissues (Figs. 29 and 
30). The negative ion mobility spectrum shows a strong peak at K> 1 -44 c m V 's '1 
which may be characteristic o f  Rompun, however, the reactant ion peak is absent. The 
Ko 1.44 c n rV 'V  peak is absent in the negative ion spectrum of Ketaset. Additional 
work would need to be performed with a more selective reactant ion to better 
understand the mobility spectrum. A preliminary calibration curve for each anesthetic 
was obtained in the positive mode and is shown in Fig. 31. The concentrations ranged 
from Ing/uL to 100 ng/p.L. Additional runs are needed using specific matrices to match 
experimental conditions before quantitative work is attempted.
To determine if Rompun and Ketaset (and possibly other components) could be 
extracted from tissues, 50 —70 mg o f C3 atrial, ventricle and lung tissue were gently 
shaken in 1 mL of methanol and/or 1 mL o f acetonitrile and allowed to stand for 
approximately 18 hours. Five p.L o f supernatant from each mixture as well as the tissue 
residues were analyzed by IMS (Table 11). It appears that Rompun and/or Ketaset can 
be recovered from the tissues under the conditions described based on the Ko, 1.38-1.39 
crrrV 's"1 peaks found in the extract. Methanol appears to be a better solvent than 
acetonitrile based on the higher peak amplitudes.
Another peak (Ko 1.30 c m V s ' 1) was observed in the extracts. In this case, 
acetonitrile appears to be the better solvent with higher amplitudes being observed than
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Figs. 29A and 29B. IMS mobility spectra of 100 mg/mL Rompun in the positive ioi 
(A) and negative ion (B) modes.
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Figs. BOA and BOB. IMS mobility spectra of 100 mg/mL Ketaset in the positive ion (A) 
and negative ion (B) modes.
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Fig. 31. Calibration curves for 1,5, 10, 25, 50, and 100 ng/pL o f separate solutions o f 
Rompun and Ketaset in saline.
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Table 11
Peak Ko values and amplitudes for C3 animal tissues extracts
Animal Tissue Extract Solvent Peak
Number
Ko
c m V s ’1
Amplitude
(du)
Atrial Supernatant Methanol 1 1.39 169
2 1.30 257
Acetonitrile 1 1.38 107
2 1.30 419
Atrial Tissue Residue Methanol 1 1.38 162
2 1.30 284
Acetonitrile 1 1.39 204
2 1.30 557
Lung Supernatant Methanol 1 1.39 339
Acetonitrile 1 1.38 128
2 1.30 328
Lung Tissue Residue Methanol 1 1.65 62
2 1.30 159




Ventricular Supernatant Methanol 1 1.39 461
2 1.30 254
Acetonitrile 1 1.38 222
2 1.30 23
Ventricular Tissue Methanol 1 1.38 124
Residue 2 1.30 439
Acetonitrile 1 1.65 84
2 1.38 340
1.30 419
from methanol. As discussed in Chapter IV, the source o f the 1.30 cm2V '1s '1 peak 
appears to be from heparin administered to animals. However, heparin is also 
biosynthesized and stored in mast cells o f various animal tissues, particularly liver, lung
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or gut [43], Tissues were not available from animals that had not received heparin to 
check whether 1.30 cm2V 'ls‘l the peak was inherent to the tissue.
Alkylating Agents
Mobility spectra o f 2-chloroethyl ethyl sulfide and methyl iodide (as received 
w ithout d ilu tion) were measured in both negative (Fig. 32) and positive modes (Figs. 33 
and 34). Mixtures o f the alkylating agents and brain tissue were analyzed by IMS to 
determ ine any changes in the tissue mobility spectra. Two brain tissues were examined. 
C3 (from  animals that had received excess Ketaset), and C4 (from an animal that did 
not receive anesthetic). The negative mode mobility spectra of C4 brain tissue alone 
and after exposure in vitro to 2-chloroethyl ethyl sulfide are shown in Figs. 35A and 
35B, respectively. Although, there was not a shift or elimination o f peaks, the spectrum 
does show  a major decrease in the intensity of one o f the tissue peaks (Ko 1.54 
c m V s '1) implying alkylation.
It is interesting to note that the negative ion mobility spectrum of C4 brain tissue 
(no anesthetic) shows peaks with Ko 1.54 and 1.50 c m V s ’1 (Fig. 35A), whereas the 
negative ion mobility spectrum of C3 brain tissue (excess Ketaset) shows only Ko 1.50 
c n rV 's '1. This is another example that the negative ion IMS should be examined in 
more detail with animal tissues. A similar experiment was performed with undiluted 
methyl iodide and C4 brain tissue. No changes were apparent (Fig. 36), however, the 
results were inconclusive. Reactions of methyl iodide occurred as evidenced by the 
very intense peak at Ko 2.34 c n rV 'V  most likely iodide ion. The electron affinity of 
the iodide coupled with its high concentration did not allow the ion peaks from the 
tissue to be visible due to competitive reactions. C3 brain tissue with anesthetic was
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Figs. 32A and 32B. IMS mobility spectra o f (A) 2-chloroethyl ethyl sulfide (500 
ng/pL) and (B) undiluted methyl iodide in the negative ion mode.
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Fig. 33. The positive mode mobility spectrum o f 500 ng/p.L 2-chloroethyl ethyl sulfide.
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Fig. 34. IMS mobility spectrum o f undiluted methyl iodide in the positive ion mode.
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Figs. 35A and 35B. The negative mode mobility spectra o f (A) C4 brain tissue 
alone and (B) after exposure in vitro to 500 ng/pL 2-chloroethyl ethyl sulfide.
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Fig. 36. Negative ion mobility spectrum of undiluted methyl iodide mixed with C4 
brain tissue.
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exposed in vitro to methyl iodide and 2-chloroethyl ethyl sulfide. These results are 
shown in Figs. 37A, 37B. and 37C. Some methyl iodide reacted as judged by the 
appearance of the peak at Ko 2.33 c n r V 'V .
Reactions of C3 brain tissue with 2-chloroethyl ethyl sulfide were also checked 
using the positive mode o f IMS. Figs. 29, 38, 39, and 40 show Rompun alone, Rompun 
with 2-choroethyl ethyl sulfide, C3 brain tissue control, and C3 brain tissue with 2- 
chloroethyl ethyl sulfide. It is clear from Figs. 29 and 38 that addition o f  2-chloroethyl 
ethyl sulfide leads to a decrease o f the peak amplitude at Ko 1.38 c m V s '1. However, 
no decrease of the same peak was noted in a similar treatment of C3 brain tissue.
A new peak (Ko 1.16 cm2 V ',s I) appeared in the mobility spectrum for C3 brain 
tissue control. Checking several samples gave the same results. The Teflon membranes 
used for the particular sampled did not show the peak. Though the tissues were stored 
in the freezer they were several months old. It appears that the peak may be due to 
tissue decomposition in storage or the introduction o f an impurity. The Ko of 1.16 
c it t V ' s' 1 corresponds to that o f cocaine but the animals were not treated with cocaine. 
Vegetable Proteins and Polyglycines
The mobility spectrum for Protein 94 is shown in ChapterVI. The spectra for 
polyglycines and Slim Fast, are given in Appendix B.
Amino Acids
The positive and negative mode Ko values and amplitudes o f several amino 
acids are listed in Table 12. As expected, the positive and negative ion mobility spectra 
are different for the same amino acid. In the case of arginine and tyrosine, no ion peaks














60 4 8 1210 14 16 2018
1 00 0 
9 0 0  
8 0 0  
7 0 0
■3 6 0 0
gf)
*5 300
ss 4 0 0cja.
Drift Time (ms)










6 8 124 10 14 16 2018
D r i f t  T i m e  ( m s )
Figs. 37A and 37B. Negative ion mobility spectra o f (A) C3 brain tissue and (B) C3 
brain tissue exposed in vitro to undiluted methyl iodide.
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Fig. 37C. The negative ion mobility spectrum of C3 brain tissue exposed in vitro to 500 
ng/pL 2-chloroethyl ethyl sulfide.
1 0 0 0  -   - — -     - - . -- -
9 0 0  
8 0 0  
7 0 0
2 - C h l o r o e t h y  1 E th y l  S u l f i d e  a n d  R o m p u n
6 0 0
ef.






Rea c ta n t  Ion Peak
1.65
8 102 4 6 12 I 8 2 0I 4 16
Drift Tim e (ms)
Fig. 38. Positive mode spectrum o f a mixture o f 100 ng/pL Rompun and 500 ng/pL 2- 
chloroethyl ethyl sulfide.
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Fig. 40. Positive mode mobility spectrum of C3 brain tissue exposed in vitro to 500 
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Table 12




Positive Mode Negative Mode
Ko Amplitude Ko Amplitude
(c n rV 'V 1) (du) ( c m V s '1) (du)
Glycine 1 1 . 1 2 2 2 . 2 1.85 136.6
2 1 . 2 2 58.9
Phenylalanine 1 1.36 127.0 1.87 99.0
2 1.32 38.2 1.81 62.2
j 1.26 32.3 1.40 45.1
4 1.06 117.0 1.06 41.0
Glutamine 1 No signal 1.25 197.2
detected
Tyrosine 1 1 . 6 6 216.3 No signal
2 1 . 2 2 39.7 detected
J 1.17 58.9
Cysteine 1 1.71 72.2 1.46 263.4
2 1.61 45.1 1.37 95.2
-i 1.46 75.8 1.30 133.1
Arginine 1 1.67 46.2 No signal
2 1.42 16.4 detected
Histidine 1 1.70 63.9 1.53 183.0
2 1.43 27.7 1.25 79.1
were noted in the negative mode. In some cases, a signal was observed in only one of 
the modes. The amino acids with peaks of highest intensity were tyrosine and 
glutamine in the positive and negative modes, respectively (Figs. 41A and 4 IB). These 
amino acids were dissolved to determine any difference in mobility spectra in 
comparison to the solid. Tyrosine was dissolved in a dilute HC1 solution and glutamine 
was dissolved in water. Both solutions were hydrophobic to the Teflon membrane used, 
and were analyzed instead on S&S paper and QMA. A positive ion mobility spectrum 
similar to that from solid was observed with tyrosine, but no signal was found for 
glutamine. The concentrations were 1000 ng/mL for tyrosine and glutamine in solution.
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Discussion
Chemistry studies using IMS have shed additional light on the origin o f  the four 
ion peaks found in the tissues from rabbit organs. Solvent extractions of tissue samples 
showed that the compounds associated with ion peaks of Ko 1.38 and 1.30 c m V s ' 1 
easily extractable. Mobility spectra that illustrate extraction results with C3 atria, lung 
and ventricle are shown in Appendix C. As shown in Table 11 and Fig. 42 control atrial 
tissue does not exhibit ion peaks with Ko 1.65 and 1.51 c m V s '1. However, there is a 
medium intensity peak at Ko 1.37 c n rV 'V 1 and a strong ion peak at 1.29 c ir rV 'V .
The IMS of both methanol and acetonitrile extracts of atrial tissue showed peaks at Ko 
1.38 and 1.30 cm2 V 'ls '1, although the components responsible for the peaks were not 
completely extracted. The same ion peaks, though lower in intensity, were noted in the 
IMS of the tissue residues. Results with lung tissue were similar. Use o f methanol 
seems to be more efficient than acetonitrile in extracting the components corresponding 
to Ko 1.38 and 1.30 cm2 V'ls '1. No ion peaks associated with Ko 1.65 and 1.52 cm 2 V '1s' 1 
were noted for the residues (supernatant). Methanol seems to exhibit a retardation 
effect on the IMS of tissue residues after extraction (Table 12). This might be protein 
denaturization resulting in blocking components from volatizing in the IMS desorption 
process. Retardation effects were also noted in residual tissues from methanol and 
acetonitrile extraction of ventricle tissues especially with the ion peaks o f Ko 1 -38 and
1.30 c m V s ’1.
The extraction data are consistent with assignment of ion peaks with Ko 1 -38 and
1.31 c it t V ' s' 1 to Rompun/Ketaset and heparin, respectively. Both compounds should 
be soluble in methanol and acetonitrile. The components associated with Ko 1.65 and
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Fig. 42. Positive ion mobility spectrum of C3 atria.
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1.52 c rrrV 'V  did not extract. This adds evidence that they are innate to the tissues and 
probably arise through thermal decomposition during desorption. Solubility in the 
methanol and acetonitrile would have been expected.
A number of solid materials were screened with IMS to check whether any ion 
peaks similar to those from rabbit tissues were found. These included vegetable and 
synthesized proteins, sugars, humic substances and amino acids. A listing o f these 
mobility spectra are shown in Appendix D. A summary o f the IMS results for the 
amino acids screened are given in Table 12. Four of the amino acids showed positive 
ion peaks between 1 . 6 6  and 1.71 c m V s " 1. As mentioned above, the strongest peak in 
the positive mode was exhibited by tyrosine. This could be the source o f the 1.65 
c n rV 's "1 peak in animal tissues. The amino acid with the closest peak to the animal 
tissue peak of 1.50 c m V s ' 1 was cysteine with a Ko of 1.46 c m V s '1. It should be 
noted that the Teflon control membrane exhibited a very weak peak with a Ko value of 
1.65 c n rV ’s' 1 (Fig. 43). It was surprising to find that vegetable protein (soy protein 
isolate) showed no peaks, however, the content of tyrosine was only 3.3%. Another 
product (Slim Fast ®) containing yet smaller amounts of vegetable protein but many 
other components shows several very weak peaks were found, but nothing 
corresponding to those found with animal tissue. Three humic substances were also 
screened (Appendix D). A single ion peak with low mass was found (Kol .97 
c m V s ’1). However, it did not correspond to those observed with animal tissues. 
Alkylation Agents
The reaction o f animal tissues with alkylating agents was examined using IMS 
in both the negative and positive modes. The idea was to allow two different, but well

























0 2 4 6 8 10 12 14
Drift Time (ms)
Fig. 43. Positive ion mobility spectrum of Teflon.
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known alkylating agents, 2 -chloroethyl ethyl sulfide and methyl iodide, to react with 
high electron density centers in the animal tissues and follow effect on ion peaks in the 
tissues. For example, alkylation o f accessible Rompun in tissues should lead to a salt 
which would be much less volatile (Fig. 44A). The Ko 1.38 cm 2 V '1s '1, ion peak in the 
positive mode should decrease proportionately. If the salt dissociates during thermal 
desorption to a tertiary amine, the Ko should shift to a lower value due to the increased 
ion mass (Fig. 44B).
Negative ion mobility spectra o f brain tissue C4 after the reaction with 2- 
chloroethyl ethyl sulfide and methyl iodide gave indication that reaction occurred, but 
shed no light on reaction sites. The mobility spectra of brain tissue C3 in the negative 
mode was interesting in view o f the strong ion peak at Ko 1-50 cn T V 'V  (Fig. 37A). 
However, addition o f methyl iodide to the tissue did not affect the intensity (Fig. 37B 
and 37C). The peak is not due to Rompun as verified by its negative mode mobility 
spectra (Fig. 29). It might also arise from a metabolite of Rompun or Ketaset. It is 
interesting and needs to be explored further.









Fig. 44. Equation A represents the alkylation of Rompun. Equation B represents the 
dissociation of the salt to a tertiary amine.
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CHAPTER VI
IDENTIFICATION OF FACTORS THAT INFLUENCE THE 
ION MOBILITY SPECTROMETRY DETECTION OF 
CONTRABAND DRUGS
Introduction
We have hypothesized that there may be enhancement and retardation effects 
that impact the utility o f  IMS in clinical chemistry. The specific aim o f the present 
chapter is to identify factors that influence IMS analysis using cocaine, heroin, and their 
metabolites as an illustration of what might be encountered in the clinical laboratory and 
in clinical chemistry research. Experiments were performed to determine IMS 
properties of mixtures o f cocaine and its decomposition products. Effects o f proteins, 
amino acids, and small glycine peptides on the IMS characteristics o f heroin were also 
examined.
Cocaine and its Metabolites
Cocaine is an alkaloid and potent CNS stimulant that elicits a state o f increased 
alertness and euphoria. CNS effects are thought to occur when cocaine blocks 
neurotransmitter reuptake, and prolongs the action of dopamine. Although cocaine is an 
effective local anesthetic and vasoconstrictor, it can produce sympathomimetic 
responses that include an increase in blood pressure, heart rate and body temperature 
[48].
Cocaine is rapidly metabolized by liver esterases into the metabolites, ecgonine 
methyl ester (EME) and benzoylecgonine (BE) (Fig. 45). Cocaine may also be 
converted to EME by the action o f serum pseudocholinesterase and to BE by
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Fig. 45. Structures of cocaine and its common metabolites/decomposition products.
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spontaneous hydrolysis [49]. A thermodegradation product o f cocaine is 
anhydroecgonine methyl ester (AEME) (Fig. 45), and is often found in the urine of 
those who smoke cocaine [50]. In the presence o f ethanol, liver carboxyesterase 
catalyzes the tranesterification of cocaine to cocaethylene (also called ethylcocaine)
(Fig. 45). Cocaethylene has the same effects o f cocaine and may enhance the 
stimulatory effects on the CNS.
Cocaine's metabolites can be identified using for example, enzyme multiplied 
immunoassay technique (EMIT) (300 ng/pL cut-off) [48]. Another technique used for 
confirmatory analysis is gas chromatography/mass spectrometry (GC/MS). This requires 
liquid-liquid extraction, solvent evaporation, and treatment with N-methyl-N- 
trimethylsilyltriflouroacetamide (MSTFA) to form EME and BE derivatives [49].
Much information is available in the literature on cocaine detection, identification, and 
analysis [9],
Heroin and its Metabolites
Morphine and heroin are two drugs in the class o f opiates, which are very 
effective painkillers (Fig. 46). Morphine is an active ingredient o f opium. Opiates slow 
down the central nervous system and can reduce hunger. Specifically, opiate 
derivatives stimulate opiate kappa receptors and depress the release of acetylcholine 
[35], Morphine is targeted for excretion from the body through glucuronide 
conjugation at one o f  its hydroxyl groups. Heroin (diacetylmorphine) is preferred by 
opiate abusers because o f its rapid onset o f action, although this derivative of morphine 
is itself not active. (Heroin is rapidly converted to 6 -acetylmorphine and then to
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Fig. 46. Structures o f heroin metabolites or derivatives.
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morphine). 6 -AcetyImorphine is a metabolite and a hydrolysis product o f heroin (Fig. 
46). Both heroin and 6 -acetylmorphine are hydrolyzed to morphine.
Heroin is synthesized from morphine base by heating with acetic acid anhydride; 
its hydrochloride is very soluble in water [39]. Heroin and its metabolites, as in the 
case of cocaine and its metabolites, are currently analyzed in the clinical laboratory by 
EMIT (300 ng/pL cut-off for morphine) and GC/MS [48]. Commercial immunoassays 
are designed to primarily detect morphine and codeine (synthesized by the
3-methylation of morphine, (Fig. 46). Some cross-reactivity with morphine-3- 
glucuronide and other opiates) is reported [49]. GC/MS procedures include treatment 
with P-glucuronidase, extraction with a solid-phase absorbent, elution, solvent 
evaporation, and treatment with MSTFA reagent to form trimethylsilyl derivatives of 
opiates [49],
Results
Cocaine and its Decomposition Products
It has been shown that IMS is a convenient tool to detect and identify cocaine 
reaction products [9]. K0 values for cocaine and its common reaction products are given 
in Table 13.
The compounds can be differentiated based on K0 values though detection limits 
vary widely. Two studies were performed to identify factors that may effect the IMS 
analysis cocaine. In one case, mixtures of AEME and EME (two decomposition 
products of cocaine) were analyzed in the presence o f each other. In the other case, the 
same compounds were analyzed in the presence cocaine.
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Table 13
K0 values for cocaine and its common reaction products [39]
Compound Ko






Cocaethylene 1.12 and 1.42
IMS of Anhydroecgonine Methyl Ester (AEME) and Ecgonine Methyl Ester 
(EME) Mixtures. IMS was used for the identification and analysis of AEME and EME 
in the presence o f each other. As shown in Table 13, these compounds exhibit ion 
mobility values which are relatively close (reduced mobility constants, K0: 1.50 and 
1.48 c n rV 'V , respectively). Studies involving cocaine reactions may require 
differentiation of AEME and EME. Calibration curves for AEME and EME are shown 
in Figs. 47A and 47B. Analytical information can be obtained from less than a 
nanogram to approximately 30 ng. Above 30 ng, the system becomes saturated and 
little increase in peak intensity occurs.
It was found that IMS peaks from AEME and EME mixtures could not be 
deconvoluted using the instrument software. The K0 values and average amplitudes for 
these mixtures are given in Table 14. The peak amplitudes from AEME/EME mixtures 
were about 50% lower than expected by adding amplitudes o f individual components 
using their calibration curves. This is not surprising with higher amounts because o f 
saturation effects but was unexpected for lower amounts. It is probable that amounts of
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Fig. 47. Ion mobility spectrometry calibration curve for (A) EME (0-100 ng) and (B) 
AEME (0-100 ng).
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Table 14
Ion mobility spectrometry results using mixtures of anhydroecgonine methyl ester 
(AEME) and ecgonine methyl ester (EME)
Weight Ratio 





1 0  / 0 1.504 ±0.000 692 ±25
1 0  / 1 0 1.502 ±0.002 531 ±13
1 0  / 2 0 1.490 ±0.003 547 ±27
10 / 40 1.485 ±0.000 692 ±27
1 0  / 60 1.484 ±0.000 815 ±25
1 0  / 80 1.483 ±0.000 856 ±7
0  / 1 0 1.485 ± 0.000 406 ±22
1 0  / 1 0 1.502 ±0.000 531 ±13
2 0  / 1 0 1.493 ±0.000 684 ±19
40 / 10 1.495 ±0.000 750 ±12
60 / 1 0 1.494 ±0.000 772 ±7
80 / 1 0 1.496 ±0.000 801 ±24
either AEME or EME may be underestimated when both compounds are present. This 
is may be due to effects of peak shape but was not investigated further. AEME shows 
higher sensitivity to IMS than does EME (Figs. 47A and 47B) but is of little 
consequence in attempting to analyze mixtures.
Table 14 shows K̂ , values for combinations in which one component is held at 
1 0 ng and the other is varied up to 80 ng. As EME amounts are increased (holding 
AEME at 10 ng) the K0 values decrease until the K0 o f EME is reached. The peak 
amplitudes decrease for AEME/EME ratios of 10 ng/10 ng and 10 ng/20 ng, and then 
increase. The observed decrease may be due to factors such as the lower sensitivity of 
IMS to EME (Figs. 47A and 47B), peak shape, and/or instrument variability. As
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AEME amounts are increased (holding EME at 10 ng), the highest K0 values were 
found at AEME/EME ratios of 10 ng/10 ng and 80 ng/10 ng. An interesting finding is 
that at a 10 ng/10 ng weight ratio o f AEME/EME, the K0 value (1.50 cm2 V 's '1) 
indicates the presence o f AEME. A K„ value of 1.49 c n rV 'V  is difficult to interpret as 
to relative amounts o f AEME and EME that might be present.
It is clear from the data in Table 14 that K,, values cannot be used to differentiate 
AEME from EME in their mixtures. (It may also be difficult to identify these 
compounds using IMS in the presence of other substances which have similar ion 
mobilities.) Unequivocal identification of AEME and EME would require use of an 
independent technique such as GC-MS. In some applications, it may be very important 
to differentiate AEME from EME for identification of cocaine. One might be able to 
separate IMS peaks for AEME and EME using carrier and drift gases other than air, 
however, this was not investigated.
Enhancement o f IMS Sensitivity to Cocaine. IMS was used to examine the 
effect of AEME and other compounds on cocaine sensitivity. Studies were also 
performed using different sample membranes to detect surface effects on cocaine IMS 
sensitivity.
It was observed that the addition of a little as 1 ng AEME may significantly 
increase cocaine hydrochloride IMS sensitivity. Fig. 48 illustrates results from adding 1 
ng of AEME to 1,5, 10, and 25 ng each of cocaine hydrochloride. In each case there 
was a relative increase in the amplitude of the cocaine ion peak. Addition of 1 ng 
AEME to 5 ng cocaine hydrochloride resulted in a 50% increase o f the cocaine peak
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Fig. 48. IMS peak amplitude average increases as a result o f adding 1 ng AEME to 1,5, 
10. and 25 ng cocaine hydrochloride (K0, 1.16 cnrV^s'1).
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amplitude. Addition of more than 1 ng of AEME to 5 ng o f  cocaine hydrochloride did 
not lead to further increases of the cocaine signal. This is illustrated in Fig. 49.
The effect o f adding cocaethylene, benzoylecgonine, ecgonine hydrochloride, 
morphine. 6 -acetylmorphine, codeine, and heroin on IMS sensitivity o f cocaine was also 
examined. In these experiments 25 ng of each substance was added to 5 ng of cocaine 
hydrochloride. There was an increase in the IMS sensitivity o f cocaine in all cases 
except cocaethylene and only a slight increase was seen with the addition of 
benzoylecgonine (Fig.50). This demonstrates that compounds other than AEME may 
increase cocaine hydrochloride IMS sensitivity as well. It is important to note that such 
effects may also be caused by solvent. For example when 1 p.L of acetonitrile was 
individually applied to nanogram amounts of cocaine (5 - 25 ng), small increases in 
cocaine IMS sensitivity were observed (Fig. 51). The acetonitrile was allowed to 
evaporate for one minute before the analyses were performed.
Four membranes/papers were compared relative to overall effects on IMS 
sensitivity to cocaine. These included Barringer fiber glass membranes, Whatman filter 
paper, and Schleicher & Schell (S&S) papers and Barringer Teflon membranes 
(normally used). Fig. 52 shows that the sample matrix used may significantly affect the 
amplitude of cocaine. Barringer fiber glass appears to retard the cocaine peak the most, 
with S & S  paper having the least effect, both relative to Teflon. An increase in the 
cocaine signal was still observed, however, with the addition o f 10 ng AEME to 5 ng 
cocaine, with each sample matrix. The best effect was noted with Whatman filter 
paper. However, in no case was the amplitude increase greater than that observed with
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î>
<  cocHCI+l ngAEME . • J 1 |
cocHCl+O.SngAEME I ~ ~- ■" '  | ——H
5 ng cocHCI \
0 20 40 60 80 100 120
Peak Amplitude (du)
Fig. 49. IMS peak amplitude changes as a result of adding AEME (0.5. 1. 5, 10, and 25 
ng) to 5 ng cocaine hydrochloride (K,,, 1.16 c n rV 's '1).
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Fig. 50. IMS peak average amplitude changes as a result o f adding various substances 
to 5 ng cocaine hydrochloride (K0, 1.16 c n rV 's '1).
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Fig. 51. IMS peak amplitude change as a result of applying 1 pL o f acetonitrile to 5. 
10. and 25 ng of cocaine hydrochloride prior to analysis.
Barringer Teflon
Barringer Fiber Glass .___.
= Wham™ Filter Paper
■TocHCl
H ocH C l 
+ AEME
Schleicher&Schell
0 50 100 150 200 250
Average Peak Amplitude (du)
Fig. 52. Effect of sample membrane on the IMS peak amplitude o f cocaine 
hydrochloride alone and in the presence o f AEME.
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Teflon and AEME. It is clear that clinical laboratory practitioners and researchers need 
to choose a sample matrix that best suits their needs. For example, though Teflon may 
provide the highest sensitivity for cocaine, an aqueous sample would better be analyzed 
with a paper filter or other surface which easily absorbs water.
IMS sensitivity effects on cocaine ion peak amplitude were explored in the 
presence of AEME and animal tissues. Weight ratios of 1:5, 5:1, 2:5, and 5:2 of cocaine 
hydrochloride to AEME were separately deposited on 0.5-1 mg A43 brain tissue. The 
controls were cocaine hydrochloride alone and cocaine hydrochloride in the presence 
and absence o f tissues. It was found that the presence o f animal tissue decreases the 
cocaine signal amplitude by as much as two thirds. However, in the presence of AEME 
and brain tissue the cocaine signal amplitude decrease is much less and in cases falls 
within the standard deviation. Additional work is required to more fully understand the 
effect. It is clear however, that based on preliminary results, analysis o f cocaine and its 
decomposition products using IMS may be limited to qualitative applications.
Benzoylecgonine. BE is the major hydrolysis product formed in the metabolism 
of cocaine (Fig. 53). It is the major cocaine metabolite found in hair and urine [8 ]. The 
IMS mobility spectrum of 200 ng o f BE from methanol solution is shown in Fig. 54. A 
calibration curve is given in Fig. 55. The IMS response to BE was found to be about
4-5 times lower than that for cocaine (see Fig. 8  for comparison).
The peak at K0, 1.18 cm ^V 'ls'l, is attributed to BE with an ion mass of 289 [39]. 
At BE concentrations o f 100 ng and above, a second peak appeared (K,, 1.63 cm^V-ls*!).

















Fig. 53. (A) Benzoylecgonine is a major hydrolysis product formed in the metabolism 
of cocaine. (B) Elimination of benzoic acid from benzoylecgonine gives ecgonidine.
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Fig. 55. IMS calibration curve for benzoylecgonine.




This may be a decomposition product formed during IMS thermal desorption or an 
impurity in the sample.
We speculate that the K0, 1.63 cm-V* • s" 1. peak is from ecgonidine formed in the 
elimination o f benzoic acid from BE (Fig. 53). This is analogous to the elimination o f 
benzoic acid from cocaine to form AEME. This peak also appeared during a time in 
which the QA/QC daily checks with cocaine showed above average amounts o f AEME 
being formed. It appears that a contaminant in the IMS system was facilitating the 
benzoic acid elimination.
Hydrolysis o f BE to ecgonine was eliminated as a source of the 1.63 cm2 V*ls'l 
peak since the K0 for ecgonine is 1.55 cm2 V*1s_ 1 (Table 13). However, deconvoluting 
the K,,, 1.63 cm2 V_1 s*l , ion peak for 200 ng o f BE did show an unidentified peak with 
lower intensity at K0, 1.59 cm2 V'*s-* .
Experiments were performed with mixtures o f BE and cocaine to detect any 
major anomalies in the resulting IMS mobility spectra during a period in which 
difficulties were being experience with the ion mobility spectrometer. Fig. 56 shows 
the mobility spectrum for 25 ng cocaine hydrochloride. The cocaine peak is much 
lower than usual, and the AEME peak is higher.
The major peak in the mobility spectrum (Fig.57) of a mixture o f 25 ng cocaine 
hydrochloride and 200 ng BE was deconvoluted into two peaks, K,,, 1.19 cm2 V-ls- 1  
(amplitude 56), and K0, 1.17 cm2 V-, s*l (amplitude 535) (cocaine). It is interesting to 
note that the BE peak is appreciably retarded, but with an increase in the ecgonidine/BE 
peak ratio. On the other hand, the cocaine peak is significantly enhanced with a major
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Fig. 56. IMS mobility spectrum for 25 ng cocaine hydrochloride. The cocaine peak 
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Fig. 57. IMS mobility spectrum o f 200 ng benzoylecgonine and 25 ng cocaine 
hydrochloride. The peak at FC0, 1.17 cn rV 'V  can be deconvoluted into two peaks.
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decrease in the intensity o f  the AEME decomposition product o f cocaine. The 
experiment was repeated several times with the same result. The conclusion is that BE 
is being decomposed preferentially to ecgonidine by a contaminant in the IMS system.
It brings out the need for QA/QC protocols to establish how well the ion mobility 
spectrometer is working. Cocaine is a good candidate to use in such protocols since it is 
thermally labile giving AEME. BE appears to be similarly labile, appearing to produce 
ecgonidine. We used cocaine in QA/QC protocols as described in Chapter III, not 
realizing the potential o f BE in QA/QC until the above experiments were performed. 
Additional experiments need to be added to allow differentiation of signal 
suppression/enhancement and chemical reactions such as the elimination of benzoic 
acid.
Heroin and its Metabolites
Heroin was studied in the presence and absence of various materials to identify 
factors that influence the IMS of this compound and to better understand mobility 
spectra of tissues harvested from animals receiving heroin. K0 values for heroin and its 
common metabolites are given in Table 15. The mobility spectra of heroin show two 
peaks with K0 values o f 1.04 and 1.14 cm^V* Is-1.
One study involved analyzing heroin and 6 -acetylmorphine in the presence of 
each other. Another focused on the effect of animal tissues, proteins and amino acids on 
the IMS analysis of heroin.
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Table 15
K.0 values for heroin and related compounds [39]
Compound Ko
( c n r V s * 1)
Heroin 1.04 and 1.14
6 -Acetlymorphine 1.13 and 1.26
Morphine 1.22[17]
Codeine 1.18 and 1 . 2 1
IMS of Heroin and 6 -Actelymorphine Mixtures. As indicated in Table 15 and 
shown in Fig. 58, heroin has two IMS peaks, as does 6 -acetylmorphine. One peak of 
heroin (K0,1.14 cm2 V s * 1) is very close to one of 6 -acetylmorphine (K,,, 1.13 cnrV 's*1). 
This overlapping needs to be taken into account when analyzing samples that contain a 
mixture of heroin and 6 -acetylmorphine. More specifically, the main IMS peak of 
6 -acetylmorphine (K0, 1.13 cn rV s" ')  cannot be used alone to either identify or analyze 
6 -acetylmorphine when heroin is also present. One must use the K0, 1.26 cm2V s " ‘, 
peak.
The effect o f various amounts o f 6 -acetylmorphine on the IMS detection and 
analysis of heroin hydrochloride was examined (Fig. 59). The K,,, 1.04 cm2V*'s*‘ heroin 
peak was evident, however, its amplitude decreased with increasing amounts o f 
6 -acetylmorphine. The percentage decrease depended somewhat on the amount o f 
heroin hydrochloride. The trend is clear with the largest amount o f 6 -acetylmorphine 
(100 ng). Decreases in IMS peak amplitude (KQ, 1.04 c n r V s '1) for different amounts 
o f heroin hydrochloride were found to be: 62% (25 ng heroin), 57% (50 ng heroin), 
48% (75 ng heroin), and 32% (100 ng heroin).
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Fig. 58. IMS mobility spectra of (A) heroin hydrochloride and (B) 6 -acetylmoprhine.
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Fig 59. Effects of different amounts o f 6 -acetylmorphine on the average IMS amplitude of 
the heroin hydrochloride peak with K0, 1.04 cn rV 'V . (A) 25 ng heroin hydrochloride (B) 
50 ng heroin hydrochloride).
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Fig 59. Effects of different amounts of 6 -acetylmorphine on the average IMS amplitude of 
the heroin hydrochloride peak with K.0, 1.04 c n r V ' s ' .  (C) 75 ng heroin hydrochloride (D)
1 0 0  ng heroin hydrochloride).
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It was interesting to note that as IMS saturation levels were approached (above 50 ng 
heroin hydrochloride), appreciable amplitude decreases were still apparent for the heroin 
peak (K̂ ,, 1.04 c n rV 's '1). For example, with 75 ng heroin hydrochloride, the amplitude 
measured in the presence o f 100 ng 6 -acetylmorphine indicates only 25 ng heroin as 
determined from the heroin IMS calibration curve (Fig. 60). The results imply there is 
competition between heroin and 6 -acetylmorphine for charge with 6 -acetylmorphine 
showing higher proton affinity.
Using the same data but processing it differently allows one to examine any 
effects of varying amounts o f heroin hydrochloride on the amplitude of the 
6 -acetylmorphine peak (K0. 1.26 cm2 V 's '1). The amplitude changed slightly from 
sample to sample within a series. However, when the amplitudes from all four samples 
in a particular series were averaged, the values remained approximately the same, 
regardless of the amount o f  heroin hydrochloride present.
Effects o f Animal Tissues on the IMS Analysis o f Heroin and Morphine. An in 
vitro study of heroin in the presence of animal tissues, was conducted to better 
understand results obtained in the IMS analysis o f tissues from animals that received 
heroin. This research, conducted by Andrea Chambliss o f Dr. Barbara Hargrave’s 
research team, was important since IMS showed no heroin metabolites and only a very 
weak K„ of 1.04 cm2 V 's ' 1 for heroin (Fig. 61). Plasma samples from these studies 
showed no peaks for either heroin or its metabolites (Fig. 62). In vitro studies were 
conducted in which concentrations from 1 ng to 2 0 0  ng o f heroin hydrochloride were
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Fig. 60. IMS calibration curves for the major and minor peaks o f heroin, K,, 1.04 and 1.14
cm:V‘ls'1. respectively.
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Fig. 61. IMS mobility spectrum o f animal tissues harvested from animals that received 
heroin in vivo. The peak at KQ 1.04 c n rV ' s "1 is attributed to heroin. Peaks for heroin 
metabolites are absent.
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Fig. 62. IMS mobility spectrum o f plasma from animals that received heroin in vivo. 
Peaks for heroin and its metabolites are absent.
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added to animal tissue. A heroin signal was not observed until 200 ng were added 
(Table 16).
Table 16




Heroin peak amplitude 
(du)





1 0 139 0
15 154 0





1 0 0 279 0
2 0 0 N/A 2 1
The heroin results led to experimentation with morphine. A mobility spectrum 
of morphine is shown in Fig. 63. In mixtures with animal tissue, 8000 ng o f morphine 
were needed before an IMS signal was evident (Fig. 64). The results parallel those 
found with mixtures o f animal tissue and heroin.
Effects of Vegetable Protein on the IMS Analysis of Heroin. Proteins from a 
vegetable source (soy) (Protein 94) were also examined for possible retardation of the 
IMS signal of heroin. This was an attempt to shed more light on the heroin results 
given above. The IMS mobility spectrum of Protein 94, is shown in Fig. 65. No peaks
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Fig. 63. IMS mobility spectrum of 8000 ng o f morphine.
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Fig. 64. IMS mobility spectrum liver tissue exposed in vitro to 8000 ng o f morphine.
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Fig. 65. IMS mobility spectrum of vegetable protein (Protein 94).
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were evident other than the reactant ion peak. When attempting to analyze 100 ng of 
heroin in the presence o f vegetable protein, both heroin peaks were retarded.
Fig. 6 6  illustrates the effect o f  vegetable proteins on 25 ng, 50 ng, 75 ng, and 100 ng of 
heroin hydrochloride. The K,,, 1.04 cm2V'ls' 1 peak is significantly retarded. The Fy,, 
1.14 cm2V'ls' 1 is also retarded ( and in some cases absent) but is not shown in Fig. 6 6 .
Effects of Glycine Peptides on the IMS Sensitivity o f Heroin. Another study 
which examined the effects o f  proteins on the IMS o f heroin, was with glycine peptides. 
Glycine was chosen because it is a  simple amino acid and should give less complicated 
proteins. Glycine and its analogs may be useful models o f the interaction o f other 
proteins with heroin. The IMS mobility spectra o f the glycine peptides are shown in 
Appendix B. Figs. 67A and 67B illustrate the effects o f glycine peptides on the IMS 
sensitivity of heroin (K0, 1.04 c n rV 'V ). Glycine itself almost completely retards IMS 
peaks from 25 ng o f heroin. A small signal (18 du) remains when 50 ng o f heroin is 
analyzed with glycine. It was interesting to find less retardation with diglycine, 
triglycine, tetraglycine, and pentaglycine. However, as the number o f repeating glycine 
units increases, the retardation increases (Fig. 67A). When heroin is analyzed with 
hexaglycine, the IMS heroin signal decreases. Higher molecular weight polyglycines 
also retards the IMS signal o f heroin, but not as completely (Fig. 67B). The mobility 
spectra of the analyses o f heroin in the presence of glycine peptides are shown in 
Appendix B.
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Fig. 6 6 . Effect of vegetable protein (Protein 94) on the IMS peak amplitude (Kq, 1.04 
cnrV ^s'1) of heroin hydrochloride.
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Discussion and Conclusions
It is clear that IMS will continue to be an important tool for the detection, 
identification and semi-quantitative analysis of contraband drugs and their reaction 
products. However, it is apparent that use of IMS in semiquantitative analysis may be 
limited depending on the specific circumstances.
Cocaine and its Decomposition Products
Mixtures o f AEME and EME standards led to a single IMS peak which could 
not be resolved. Amounts of either AEME or EME may be underestimated when the 
other compound is present. IMS does not appear to be useful in estimating total 
AEME-EME.
Caution needs to be taken in reaching conclusions on compound identification 
and analysis with IMS when both AEME and EME may be present. Unexpected results 
may be explained on the basis of the similar K„ values for AEME and EME, differences 
in IMS sensitivity, and differences in proton affinity.
The IMS sensitivity to cocaine can be increased by the addition o f AEME. 
AEME decomposition/reaction in IMS does not produce ion masses similar to those 
observed in the IMS o f cocaine. Therefore, the mechanism o f signal enhancement is not 
clear. Possible factors in observing the sensitivity increase for cocaine include: an 
increase of cocaine vapor pressure, altered vapor phase chemistry in the ionization 
chamber, modification o f the Teflon surface, cooling effects by AEME on the desorber, 
and/or the neutralization of cocaine by AEME.
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Heroin and its Metabolites
6 -Acetylmorphine was found to interfere in the IMS semiquantitative analysis o f 
heroin hydrochloride, but not in its detection and identification. The presence of 
6 -acetylmorphine significantly decreases the IMS amplitude o f the heroin peak (K0,
1.04 c n rV 'V ) leading to an underestimation of the amount of heroin hydrochloride 
actually present in the sample. The effects o f heroin hydrochloride on the detection of 
the 6 -acetylmorphine peak (K„, 1.26 c n rV 'V )  are minimal. The same amount o f 6 - 
acetylmorphine is detected in those samples that contain heroin as those that do not. 
Semiquantitative analysis o f heroin hydrochloride when 6 -acetylmorphine is present 
may not be possible using IMS. Alternative methods of analysis need to be considered.
IMS is not the instrument o f choice in detecting heroin and its metabolites in 
animal tissues and vegetable proteins at low concentrations. Concentrations less than 
200 ng o f heroin and 8000 ng o f morphine were not observed in IMS analysis in the 
presence of animal tissues. Concentrations less than 100 ng of heroin did not result in 
peaks in the IMS spectra of heroin analyzed in the presence of vegetable proteins. 
Simple proteins such as glycine peptides also greatly retard the IMS signal of heroin. It 
is unclear w hy the IMS signal o f heroin is completely retarded with glycine and 
hexaglycine, but not with diglycine, triglycine, tetraglyice, pentaglycine or 
polyglyinces. The mechanism behind IMS signal quenching of heroin is most likely 
due to either a decrease in the volatility o f the heroin (e.g. by tissue interactions) or by 
ion chemistry in which volatile decomposition products o f polyglycine neutralize 
heroin's positive ions.
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It is speculated that a major cause of the heroin peak retardation is non-specific 
interaction which has not been noted previously in literature to the best of our 
knowledge. GC/MS was used to analyze 0.5 mg animal tissue mixed with 100 ng o f 
heroin placed in the GC liner. The retention times for heroin and 6 -acetylmorphine are 
13.2 and 12.5 minutes, respectively. A weak heroin peak was seen in the GC/MS 
chromatogram. Data from this study suggests that the peak quenching of heroin in the 
presence of animal tissues is influenced by a combination of non-specific interactions 
and ionization chemistry. However, it is important to note that the IMS conditions 
(temperature, etc.) could not be exactly duplicated in the GC/MS experiments.
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CHAPTER VII
PROGNOSIS ON THE USE OF ION MOBILITY SPECTROMETRY 
IN CLINICAL CHEMISTRY
Introduction
Criteria for selecting instruments for the clinical laboratory, are listed in Table 3 
(Chapter I). IMS offers many advantages related to these criteria and could be used in 
clinical laboratories and clinical research, especially in screening applications.
Although, IMS has some limitations, its technology is constantly being improved with a 
view toward expanding applications. IMS has typically been used for field screening 
for non-biological agents, but the technology has advanced to the point that it is very 
timely to consider uses in different areas, one o f which is clinical chemistry.
The need for increased effectiveness in health care diagnostics has created a 
higher demand for a greater variety chemistry of services, more rapidly and at lower 
costs. The selection process o f evaluating an instrument for clinical use considers 
economic aspects, testing rate, methodology, accuracy and precision [36]. The amount 
of sample consumed per test, methodology, the instrument’s stat (short turn around 
time) capability and user-friendliness are very important criteria. The manpower 
requirements, personnel training requirements, selectable tests for profiling, computer 
compatibility, the ability o f the instrument to flag anomalies, and the sample 
identification system employed, are also important considerations. Economic 
considerations include operating and acquisition costs, reagent and disposable item 
costs, preventive maintenance costs, manpower costs, and downtime costs. In order for 
an instrument to be considered for a clinical laboratory, the principles of operation of
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the instrument should to be well defined and potential interferences must be understood. 
The assessment o f analytical performance is conducted through evaluations to assure 
that the sensitivity, specificity, accuracy, and precision claimed can be achieved. In, 
addition, the instrument should be rugged and provide adequate operator manuals. IMS 
offers many advantages in most o f these criteria, especially those that are cost related. 
Benefits and Limitations
A review o f IMS technology versus the clinical chemistry technologies currently 
being utilized and the needs o f the clinical laboratory brought out the potential benefits 
to be gained from the use o f IMS. The major benefits are expected to be:
> Cost-effectiveness
> Ability to meet data objectives for rapid screening or semiquantitative 
analysis
> Multianalyte capability
> High level o f user friendliness
>  Minimum training requirement
> Low level o f operator expertise
> Portability
> Ruggedness
> Minimum space requirements
Advantages o f simplicity, portability, low cost, and multianalyte capability offer 
much promise in meeting performance objectives for a variety o f analytes in scenarios 
involving screening and semiquantitative analysis. IMS involves simple techniques that 
can be applied easily in screening compounds with low vapor pressures such as would
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be encountered in the clinical laboratory. This would allow screening for compounds of 
interest before utilizing sophisticated, time consuming and more expensive techniques 
such as GC-MS. Little training would be needed with IMS. Smaller or less-equipped 
laboratories can especially benefit from screening by minimizing the number of samples 
needed to be sent to reference laboratories.
IMS offers the potential o f detecting target analytes in the timely, efficient and 
cost effective maimer required in the clinical chemistry setting. Rapid analysis, coupled 
with high sensitivity and selectivity, makes IMS technology an ideal candidate to 
explore in meeting clinical chemistry needs. Relatively low cost and low consumables 
may allow large volume screening with the potential for automation.
The use of IMS in clinical chemistry will not be without limitations. Hill and 
Simpson [22] described potential problems of using IMS for field screening 
applications. Important limitations include competitive ion/molecule reactions, low 
resolution, a limited dynamic response range, ease of contamination, and use of a 
radioactive ionization source, 6 3 Ni. Currently, researchers are focused on providing
63
solutions to IMS limitations. For example, Ni has many advantages as an efficient 
ionization source, as mentioned earlier, but it also has drawbacks due to its 
radioactivity. Clark, et.al., [25] have reported a surface ionization source as an
63 .
alternative to Ni. This non-radioactive detector is a pulsed corona discharge ionizer. 
The study reports identical ion chemistry and comparable spectral responses with the 
corona source and a 63Ni source in the same instrument.
Other examples o f improvements in IMS technology include coupling extraction 
techniques, such as solid phase microextraction (SPME) with IMS [50]. This method
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utilizes SPME to sample the headspace o f solids and liquids by sorbing compounds on a 
stationary phase coated on a fused silica fiber. This paper also reports that SPME can 
be conveniently used in the IMS analysis o f cocaine vapors. SPME-IMS has been 
applied in our laboratory in confirmation with the Barringer IONSCAN 400 to bypass 
thermal degradation problems, such as the decomposition o f cocaine to AEME. This 
illustrates the inherent flexibility o f IMS technology to solve operating problems with 
simple changes o f technique. Another example of the flexibility IMS exhibits is 
illustrated in an article by Homstead and Poziomek [51]. In this case, research was 
performed to examine the chemistry of contraband drugs in the sample chamber of the 
IONSCAN 400 by manually controlling the flow of the air (carrier gas) while the 
sample is being heated. This technique provided information on the stability and 
decomposition products o f drugs at various temperatures on different surfaces. The use 
of different drift gases to enhance the separation o f compounds using IMS has been 
recently demonstrated by Asbury and Hill [52]. Different drift gases (helium, argon, 
nitrogen, and carbon dioxide) were chosen to separate compounds with similar mobility 
constants. Although, the current limitations favor the use o f IMS for screening, rather 
than quantitative work, these limitations are rapidly being overcome. It is predicted that 
IMS will be used in quantitative analysis of complicated biological molecules in the 
near future.
Benefits and Limitations of IMS in the Present Research
It has been shown that IMS can be used in the characterization of animal tissues, 
identification of drugs and metabolites in tissues, and in various clinical chemistry 
applications, such as analysis o f anesthetics, controlled substances, and metabolites.
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cocaine, EME, and heroin [1]. The high sensitivity and selectivity of the IMS allows 
specific chemicals to be detected at nanogram levels and provides excellent qualitative 
data. The analysis procedures and the operation o f the instrument were easy to 
understand and implement. The durability of the instrument made maintenance 
procedures simple and left few problems requiring repair. When there was a need for 
troubleshooting, the technical support received from Barringer was always timely and 
efficient. In addition, the IMS software allowed data to be easily accessed for 
processing. In identifying factors which could influence the IMS detection of 
contraband drugs, the ion chemistry observed provided data on novel interactions 
between compounds. The information contained in the thesis opened many windows 
for future research, e.g., medicinal applications. Expense o f  consumables (e.g.,Teflon 
membranes) were minimal. Also, the IMS procedures generated little waste.
Disadvantages included the ion mobility proneness to contamination. When this 
was encountered, the potential for data error increased as well as created the need for 
long clearance times. Another limitation was the relatively small dynamic range. The 
linear range for calibration curves often did not extend beyond 50 ng. Low separation 
efficiency, such as the case with AEME and EME, and competition in ion chemistry 
caused some difficulty in interpreting data. However, on the overall, IMS provided 
reproducible, quality data in a timely, efficient manner.
Potential of IMS with Current Clinical Chemistry Techniques
The potential to couple IMS with techniques used in clinical chemistry has 
already been established with the design of Fourier-transform (FT)-IMS [22], ion trap 
(IT)-IMS [53], IMS-MS, GC-IMS, and SPME-IMS. Pursuing tandem technology in
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clinical chemistry will expand capability, but usually with much higher cost (not true 
with SPME-IMS) IMS has been used to analyze most o f the drugs that are routinely 
analyzed using GC or GC/MS. Other instruments used for drug detection include the 
HPLC. IMS can also be interfaced with this instrument to provide substance 
confirmation and quantitative data. IMS may also play a role in the development o f 
novel immunoassays techniques. Most immunoassays rely on the detection of the 
product of the anti body-anti gen complex. Methods could be developed using an IMS 
detector with appropriate choices o f detection.
IMS has mainly been used to detect compounds with high vapor pressures. 
Many of the drugs analyzed in the clinical laboratory have this characteristic. A 
number of the analytes sent to the laboratory for diagnostic testing [54] could be 
screened using IMS. The fast detection o f narcotics in human hair, urine, and saliva 
using IMS has already been reported [8 ]. In addition, the preliminary screening using 
IMS of patients arriving with drug overdoses at hospital emergency room has also been 
reported [1 ]. Table 17 lists IMS data for prescription and illicit drugs and the method 
currently being used to analyze these substances in the clinical laboratory. This table 
further illustrates the potential o f  incorporating IMS in clinical chemistry. Ammonia, 
analyzed by spectrophotometric techniques, caffeine, detected by HPLC, and acetone, 
determined by an enzymatic assay, also have the potential to be analyzed using IMS 
technology [55]. IMS has also been used to detect the hormones, testosterone and 
progesterone, which are currently determined by immunoassay in the clinical laboratory 
[22]. However, it is important to understand that one ion reaction scheme will not be 
applicable to all analytes. IMS can be tuned to many analytes using different reactant
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Table 17
Ko values and clinical chemistry assay used to characterize prescription and illicit drugs
Drug Reported Ko of Major Ions1 
cnT V 's '1
Clinical Chemistry 
Technique [55]
Cocaine 1.16 Immunoassay, GC/MS [49]
Opiates

















Lorazepam (Ativan) 1.19, 1.22
Oxazepam (Serax) 1.23. 1.28
Nitroglycerine 1.32 Enzymatic Assay
Amitriptyline (Elavil) 1.19 GC with a nitrogen/ 
phosphorus detector
Acetominophen 1.70. 1.76, 1.97 Immunoassay
ions. The choice of reactant ion is defined by the analytical objective.
The clinical-related research efforts from this thesis illustrate that IMS is an 
important technology to pursue in meeting specific objectives. A number of research
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opportunities have surfaced as a result of the research efforts. One is the apparent 
ability of IMS to detect interactions between tissues and drugs. Continued research may 
lead to convenient methods to study the mechanism o f drug action. The identification 
of IMS peaks inherent to animal tissues may help to develop novel clinical assays for 
the rapid detection of disease markers.
A recent report indicates that a simple protein test may better predict heart 
disease than the current methods to screen for cholesterol [56]. Researchers were using 
the detection of C-reactive protein (CRP), levels to identify person prone to developing 
heart disease. Another recent finding indicates that beta-amyloid and tau proteins 
tangles and causes sticky plaque in brain nerve fibers an explanation o f Alzheimer's 
disease [57]. Our research has shown that IMS may be used to characterize and detect 
interactions with proteins. Expanding the research may lead to simple tests which can 
provide useful clinical information in a rapid, inexpensive, and unique manner. The 
prognosis for IMS use in clinical chemistry is judged to be high.




The major goal o f this thesis research was to examine IMS as a rapid screening 
tool for specific application to clinical chemistry research and laboratory use. 
Methodology was developed for target analytes representing several classes of 
physiologically active substances including anesthetics, and illicit drugs and their 
metabolites. IMS characteristics o f animal tissues and various compounds such as 
amino acids and proteins were determined.
QA/QC procedures were developed for quality data objectives relating to use o f 
IMS in clinical chemistry studies involving qualitative screening and semiquantitative 
analyses. Criteria were established for assessing the precision and accuracy o f data in 
the IMS positive ion mode, using cocaine standards. Cocaine was found to be a useful 
indicator of instrument contamination and malfunctions through a reaction involving 
elimination o f benzoic acid to form AEME. Though most o f the IMS research was 
performed in the positive mode, QA/QC procedures were also developed in the negative 
ion mode using TNT.
It was found that animal tissues harvested from rabbits can be characterized 
easily using IMS. It was found that two positive ion peaks with the same Ko values 
appear in IMS mobility spectra o f the majority of the tissues examined. These peaks 
disappear as the IMS desorption temperature is lowered, leaving the IMS window 
completely open for studies of any drugs and/or metabolites distributed in the tissues. 
The mobility spectra were also found to contain peaks assigned to the anesthetics, 
Rompun and Ketaset, and to heparin, which was used with all o f the test animals. This
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
15!
provided excellent evidence o f the potential use o f IMS in clinical chemistry. The 
peaks innate to the tissues were not identified. They varied in relative intensity between 
organs. The ion peaks may be compounds inherent to the tissue or the result o f thermal 
decomposition in the IMS desorption chamber. The IMS o f tissues represents an 
excellent area for future research and may lead to simple techniques to differentiate 
healthy from diseased tissues.
A number of interesting enhancement and retardation effects were discovered 
that affect the utility of IMS in clinical chemistry. They need to be kept in mind in IMS 
method development to gain maximum benefits from IMS technology. An example is 
the attempt to analyze two cocaine reaction products (AEME. and the biological 
metabolite. EME) in the presence o f each other. These compounds are similar in 
molecular weight and structure, can be analyzed semiquantitatively using IMS and have 
different Ko values. However, when the compounds are in the same mixture, the ion 
peaks overlap to the extent that they can not be deconvoluted. Also, the peak amplitude 
is much less than expected based on amplitudes from individual calibration curves of 
AEME and EME. It was also found in IMS studies performed with heroin and its 
metabolite, 6 -acetylmorphine, that this metabolite interferes with the semiquantitative 
analysis of heroin, but not its identification. Such problems can be solved if important 
to the data objectives. However, they serve to bring out the importance o f examining 
effects of expected components on each other when developing IMS methods.
Benzoylecgonine, another important metabolite of cocaine, was found to 
decompose using IMS, most likely with the elimination o f benzoic acid to form 
ecgonidine. This occurred during a period in which it was suspected, based on QA/QC
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procedures, that the instrument was contaminated with a material that 
catalyzed/enhanced the decomposition. It served to reaffirm the need for QA/QC 
procedures to be in place.
A nonspecific interaction of heroin an morphine with animal tissues and 
different proteins was discovered using IMS This was part o f collaborative experiments 
with the Department o f Biological Sciences to analyze tissues harvested from animal 
treated with heroin. This discovery may shed additional light on the physiological 
mechanism of opiates. It opens up an interesting use o f IMS in research and a new 
method of detecting interactions between tissues/proteins and physiologically active 
substances.
There are advantages and disadvantages in the use o f IMS in clinical chemistry. 
As the technology improves, especially in sample handling and separation using a 
simple combination o f SPME and/or GC with IMS, more and more applications will 
unfold. The thesis research provides an insight of what is possible.
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APPENDIX A 
IMS MOBILITY SPECTRA OF C3 ANIMAL TISSUES
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Fig. A -l. Positive mode IMS mobility spectra o f (A) lung tissue and (B) renal 
arterial tissue from animal C3. This animal was given vehicle saline, anesthetic, and 
euthanasia in an acute study.
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Fig. A-2. Positive mode IMS mobility spectra o f (A) brain tissue and (B) atrial tissue 
from animal C3. This animal was given vehicle saline, anesthetic, and euthanasia 
in an acute study.
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Fig. A-3. Positive mode IMS mobility spectra of (A) liver tissue and (B) kidney 
tissue from animal C3. This animal was given vehicle saline, anesthetic, and 
euthanasia in an acute study.
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Fig. A-4. Positive mode IMS mobility spectra of (A) adrenal tissue and (B) ovarian 
tissue from animal C3. This animal was given vehicle saline, anesthetic, and 
euthanasia in an acute study.
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Fig. A-5. Positive mode IMS mobility spectra o f ventricle tissue from animal C3. 
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APPENDIX B 
MOBILITY SPECTRA OF GLYCINE PEPTIDES AND TH EIR  
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Fig. B -l. IMS mobility spectra of (A) 0.5-1 mg glycine and (B) 50 ng of heroin 
hydrochloride analyzed with glycine.
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Fig. B-2. IMS mobility spectra o f (A) 0.5-1 mg diglycine and (B) 50 ng of heroin 
hydrochloride with diglycine.
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Fig. B-3. IMS mobility spectra o f (A) 0.5-1 mg triglycine and (B) 50 ng o f heroin 
hydrochloride analyzed with triglycine.
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Fig. B-4. IMS mobility spectra o f (A) 0.5-1 mg tetraglycine and (B) 50 ng o f heroin 
hydrochloride analyzed with tetraglycine.
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Fig. B-5. IMS mobility spectra of (A) 0.5-1 mg pentaglycine and (B) 50 ng of heroin 
hydrochloride analyzed with pentaglycine.
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Fig. B-6 . IMS mobility spectra o f (A) 0.5-1 mg hexagiycine and (B) 50 ng of heroin 
hydrochloride analyzed with hexagiycine.
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Fig. B-7. IMS mobility spectra o f (A) a 4600 MW polyglycine and (B) a 5200 MW 
polyglycine.
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Fig. B-8 . IMS mobility spectra o f 0.5-1 mg polyglycine (4600) analyzed with (A) 25 ng 
of heroin hydrochloride and (B)100 ng of heroin hydrochloride.
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Fig. B-9. IMS mobility spectra o f 0.5-1 mg of polyglycine (5200) analyzed with 25 ng 
heroin hydrochloride and (B) 50 ng of heroin hydrochloride.
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APPENDIX C 
IMS MOBILITY SPECTRA OF C3 ANIMAL TISSUES 
EXTRACTED WITH ACETONITRILE AND METHANOL
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Fig. C -l. IMS mobility spectra for solvent extractions o f (A) C l atrial tissue in acetonitrile 
and (B) Cl atrial tissue in methanol.
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Fig. C-2. IMS mobility spectra of atrial tissue extracted with (A) acetonitrile and (B)
methanol.
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Fig. C-3. IMS mobility spectra for solvent extractions of (A) Cl lung tissue in acetonitrile 
and (B) C 1 lung tissue in methanol.
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Fig. C-4. IMS mobility spectra o f lung tissue extracted with (A) acetonitrile and (B) methanol.
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Fig. C-5. IMS mobility spectra for solvent extractions o f (A) C l ventricular tissue in 
acetonitrile and (B) Cl ventricular tissue in methanol.
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Fig. C-6 . IMS mobility spectra of ventricular tissue extracted with (A) acetonitrile and (B) 
methanol.
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APPENDIX D 
IMS SPECTRAL INFORMATION FOR SYNTHESIZED 
PROTEINS, SUGARS, AND HUMIC SUBSTANCES
Table D-l










Vegetable (Protein 94) 0.5-1 N/A N/A N/A
Slim Fast 0.5-1 1 1.67 69
2 1.47 29
Sugars
Honey 50 1 1.65 56
2 1.56 2 0
3 1.44 2 0
Com Syrup 50 1 1 . 6 6 30
Brown Sugar 0.5-1 1 1.65 36
Maple Sugar 0.5-1 1 1.67 47
Pure Cane Sugar 0.5-1 1 1.65 -*
Maple Syrup 50 1 16.5 72
Humic Substances
Leonardite (IHSS) j .j 1 1.97 921
2 1 . 6 6 37
Aldrich (sodium salt) 0.5-1 1 1.97 179
2 1.51 53
Fluka 0.5-1 1 1.97 39
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